Allergic urticaria

L12_URTICA_ALLERG

allergic urticaria: commonly referred to as hives, is a kind of skin rash notable for pale red, raised, itchy bumps. Hives may cause a burning or stinging sensation. Histamine and other proinflammatory substances are released from mast cells in the skin and tissues in response to the binding of allergen-bound IgE antibodies to high-affinity cell surface receptors. Basophils and other inflammatory cells are also seen to release histamine and other mediators, and are thought to play an important role, especially in chronic urticarial diseases.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L50.0 Hospital discharge: ICD-9 — 7080 Cause of death: ICD-10 — L50.0 Cause of death: ICD-9 — 7080 2 out of 7 registries used, show all original rules.	3983
4. Check minimum number of events None	3983
5. Include endpoints None	3983
6. Filter based on genotype QC (FinnGen only)	3593

Control definitions (FinnGen only)

Control exclude: L12_URTICARIAERYTHEMA

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: L50
Name in latin: Urticaria allergica

NAME	L12_URTICA_ALLERG
CONTROL_EXCLUDE	L12_URTICARIAERYTHEMA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L500
HD_ICD_9	7080
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L500
COD_ICD_9	7080
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Allergic urticaria based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	34186	19774	14249
Only index persons	28832	17219	11613
Unadjusted period prevalence (%)
Whole population	0.49	0.57	0.40
Only index persons	0.56	0.63	0.44
Median age at first event (years)
Whole population	25.34	32.25	15.58
Only index persons	28.78	34.54	20.24

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3593	2567	1026
Unadjusted period prevalence (%)	0.79	0.91	0.47
Median age at first event (years)	43.72	42.07	47.86

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3757: Matched controls
37570

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

C01CA24

ATC

epinephrine; parenteral

9.2

307.7

953

1332

L50.8

ICD-10 Finland

Other urticaria

53.0

307.7

316

H02AB06

ATC

prednisolone; systemic

3.8

307.7

2442

12350

7080A

ICD-9 Finland

Urticaria, Allergic urticaria

+∞

307.7

365

XQ800

NOMESCO Finland

Prick test

5.5

307.7

738

1610

L50.9

ICD-10 Finland

Urticaria, unspecified

21.7

307.7

627

343

L50.0

ICD-10 Finland

Allergic urticaria

1574.4

307.7

3403

228

T78.4

ICD-10 Finland

Allergy, unspecified

7.8

307.7

612

918

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

4.9

304.2

796

1964

R06AE07

ATC

cetirizine; oral

3.6

301.7

2467

13088

L50.3

ICD-10 Finland

Dermatographic urticaria

40.6

299.6

182

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

14.4

218.7

201

147

L50.1

ICD-10 Finland

Idiopathic urticaria

29.5

159.3

106

H02AB07

ATC

prednisone; oral

3.1

142.5

694

2537

R06AX27

ATC

desloratadine; oral

2.4

136.7

1558

8656

J01FF01

ATC

clindamycin; systemic

2.4

128.5

1234

6324

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

5.1

122.4

269

559

R06AE09

ATC

levocetirizine; oral

2.6

113.0

801

3538

R03DC03

ATC

montelukast; oral

2.5

108.3

877

4117

T78.3

ICD-10 Finland

Angioneurotic oedema

9.1

107.1

132

149

A92

ICPC

Allergy/allergic reaction NOS

4.3

104.8

287

711

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

8.3

99.2

132

164

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

86.9

1729

11350

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.7

85.0

522

2126

R06AX22

ATC

ebastine; oral

2.3

84.9

831

4187

H02AB04

ATC

methylprednisolone; systemic

2.5

82.6

632

2858

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

81.3

1637

10718

XQ802

NOMESCO Finland

Epicutan test

3.8

81.0

263

735

R03AC02

ATC

salbutamol; inhalant

1.9

80.4

2296

16839

N05BB01

ATC

hydroxyzine; systemic

3.1

79.7

351

1191

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

5.3

76.1

155

300

J45.9

ICD-10 Finland

Asthma, unspecified

2.1

75.8

854

4528

T78.0

ICD-10 Finland

Anaphylactic shock due to adverse food reaction

20.7

72.4

E0000UV, ,

ATC

1.8

69.6

1752

12133

XQ820

NOMESCO Finland

Exposure to medicinal substance

12.4

66.8

D07AA02

ATC

hydrocortisone; topical

2.2

66.0

696

3577

L50

ICD-10 Finland

Urticaria

4.9

63.9

145

308

R06AX13

ATC

loratadine; oral

2.1

61.6

712

3781

N02AX02

ATC

tramadol; systemic, rectal

1.8

61.4

1523

10382

M79.6

ICD-10 Finland

Pain in limb

1.8

59.8

1769

12655

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.9

59.2

922

5428

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.0

58.8

798

4483

R01AD09

ATC

mometasone; nasal

1.7

58.3

1876

13708

L27.2

ICD-10 Finland

Dermatitis due to ingested food

5.8

57.6

107

190

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

5.2

57.2

118

231

J01AA02

ATC

doxycycline; systemic

1.8

56.3

2803

23074

A02BC02

ATC

pantoprazole; systemic

1.8

55.6

2467

19592

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.8

55.5

1169

7542

D07AB08

ATC

desonide; topical

2.3

55.0

489

2334

R06.0

ICD-10 Finland

Dyspnoea

1.8

54.5

1005

6221

R50.9

ICD-10 Finland

Fever, unspecified

2.0

54.1

662

3573

X49

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

6.9

53.8

122

T88.6

ICD-10 Finland

Anaphylactic shock due to adverse effect of correct drug or medicament properly administered

15.5

52.9

A02BC05

ATC

esomeprazole; systemic

1.7

52.6

1470

10240

J01FA10

ATC

azithromycin; systemic

1.7

52.2

2354

18611

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

52.2

903

5469

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

3.0

52.1

240

832

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

52.0

856

5102

Z3231

NOMESCO Finland

Registered nurse

1.8

51.9

1034

6538

D07AC01

ATC

betamethasone; topical

1.7

51.2

1347

9214

R51.80

ICD-10 Finland

Headache

1.9

51.1

754

4334

J01DB01

ATC

cefalexin; oral

1.9

49.1

3133

27096

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.7

49.0

2274

17969

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.8

48.8

1095

7146

R03BA05

ATC

fluticasone; inhalant

1.9

48.4

775

4566

D07AB02

ATC

hydrocortisone butyrate; topical

1.7

48.4

1156

7672

J01MA02

ATC

ciprofloxacin; systemic

1.7

48.2

1312

9023

M54.5

ICD-10 Finland

Low back pain

1.7

47.9

1469

10418

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.9

47.7

789

4696

L20.0

ICD-10 Finland

Besnier prurigo

2.2

47.0

437

2117

X59

ICD-10 Finland

Exposure to unspecified factor

1.9

46.9

773

4591

R03BA02

ATC

budesonide; inhalant

1.9

45.8

740

4365

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

2.3

45.6

364

1654

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

43.4

993

6477

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

43.3

586

3256

N03AX16

ATC

[U] pregabalin

1.8

42.9

808

4984

D07AC13

ATC

mometasone; topical

1.7

42.4

1056

7040

J01MA12

ATC

levofloxacin; systemic

1.9

42.4

613

3480

J01FA09

ATC

clarithromycin; systemic

1.7

42.0

1199

8283

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

41.8

743

4499

M25.5

ICD-10 Finland

Pain in joint

1.6

41.0

1308

9276

J01FA06

ATC

roxithromycin; oral

1.6

41.0

1403

10122

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.3

40.9

326

1479

Z51.6

ICD-10 Finland

Desensitization to allergens

4.3

40.3

104

245

J01MA14

ATC

moxifloxacin; systemic

2.3

40.3

329

1508

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

40.0

950

6240

A46

ICD-10 Finland

Erysipelas

2.0

39.5

470

2493

R02

ICPC

Shortness of breath/dyspnoea

1.9

39.1

516

2836

R11

ICD-10 Finland

Nausea and vomiting

2.1

38.7

411

2091

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.9

38.7

524

2906

X57

ICD-10 Finland

Unspecified privation

3.8

38.4

117

312

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

38.3

526

2930

N03AX12

ATC

[U] gabapentin; oral

1.9

37.9

574

3298

XQ801

NOMESCO Finland

Intracutantest

7.9

37.9

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

37.2

1579

11904

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

36.8

414

2149

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.7

36.7

208

804

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

3.9

36.6

107

277

J45

ICD-10 Finland

Asthma

2.0

36.4

444

2373

S98

ICPC

Urticaria

6.4

36.3

J01DA01

ATC

[U] cefalexin

1.6

36.2

2210

18017

E000001, ,

ATC

1.7

36.1

781

4980

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.0

35.0

412

2172

D07BA04

ATC

hydrocortisone and antiseptics; topical

2.0

35.0

438

2360

M54.4

ICD-10 Finland

Lumbago with sciatica

1.7

34.4

705

4422

R03AK07

ATC

formoterol and budesonide; inhalant

1.7

34.4

838

5509

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

34.4

810

5278

L23.3

ICD-10 Finland

Allergic contact dermatitis due to drugs in contact with skin

7.3

34.3

R42

ICD-10 Finland

Dizziness and giddiness

1.7

34.1

798

5190

N02BE01

ATC

paracetamol; systemic, rectal

1.8

34.0

3261

29384

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.1

34.0

336

1661

JN3AD

NOMESCO Finland

Abdominal CT examination

1.9

33.8

463

2569

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

33.7

1513

11473

J45.8

ICD-10 Finland

Mixed asthma

3.1

33.6

140

457

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.1

33.5

352

1779

P01AB01

ATC

metronidazole; oral, rectal

1.5

33.0

1465

11068

S01GX01

ATC

cromoglicic acid; ophthalmic

1.6

32.8

849

5659

D11AH01

ATC

tacrolimus; topical

4.7

32.7

161

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

32.5

690

4364

X58

ICD-10 Finland

Exposure to other specified factors

1.8

32.3

600

3657

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

32.2

497

2864

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.5

32.1

212

883

R03AC03

ATC

terbutaline; inhalant

1.8

31.7

532

3145

R01AD08

ATC

fluticasone; nasal

1.6

31.4

1083

7720

R03BB04

ATC

tiotropium bromide; inhalant

2.1

31.1

311

1543

Z71.8

ICD-10 Finland

Other specified counselling

1.5

31.0

1365

10258

S29

ICPC

Skin symptom/complaint other

1.7

30.9

766

5039

R05

ICPC

Cough

1.6

30.9

988

6917

J20

ICD-10 Finland

Acute bronchitis

1.9

30.8

418

2311

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

30.8

741

4840

N30.0

ICD-10 Finland

Acute cystitis

1.7

30.7

705

4549

UJF32

NOMESCO Finland

Coloscopy

1.6

30.6

807

5391

A02BA02

ATC

ranitidine; systemic

1.8

30.6

577

3527

XQ899

NOMESCO Finland

Other assessment of skin

8.6

30.5

M03BX02

ATC

tizanidine; oral

1.5

30.4

2220

18462

S88

ICPC

Dermatitis contact/allergic

3.3

30.4

114

349

R60.9

ICD-10 Finland

Oedema, unspecified

2.4

30.3

213

912

G44.2

ICD-10 Finland

Tension-type headache

1.7

30.3

578

3543

XG474

NOMESCO Finland

Exhalation nntrogen oxide

3.1

30.1

126

413

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

29.9

1052

7515

R01AD58

ATC

fluticasone, combinations; nasal

1.6

29.9

1058

7571

R52.9

ICD-10 Finland

Pain, unspecified

1.9

29.8

400

2202

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.2

29.7

255

1191

L17

ICPC

Foot/toe symptom/complaint

1.5

29.7

1110

8037

E000002, ,

ATC

1.9

29.6

446

2547

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

29.5

593

3686

A02BC01

ATC

omeprazole; systemic

1.6

29.5

900

6222

R01AD12

ATC

fluticasone furoate; nasal

1.5

29.4

1275

9522

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.0

29.3

347

1829

J02AC01

ATC

fluconazole; systemic

1.5

29.3

1509

11672

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

28.8

1031

7385

J45.1

ICD-10 Finland

Nonallergic asthma

2.1

28.5

284

1405

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.8

27.8

139

503

AA1AD

NOMESCO Finland

CT of head and brain

1.6

27.8

855

5909

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.9

27.8

355

1920

Z3226

NOMESCO Finland

Physiotherapist

1.7

27.6

631

4053

A01

ICPC

Pain general/multiple sites

1.9

27.2

389

2184

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.9

27.1

385

2155

R03BA01

ATC

beclometasone; inhalant

1.8

27.0

482

2892

R96

ICPC

Asthma

1.9

26.8

379

2118

R01BA52

ATC

pseudoephedrine, combinations; oral

1.5

26.7

988

7105

J01FA01

ATC

erythromycin; systemic

1.7

26.7

567

3570

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

26.6

868

6074

W84

ICD-10 Finland

Unspecified threat to breathing

9.2

26.5

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.1

26.5

267

1327

Z2221

NOMESCO Finland

Medical doctor

1.5

26.5

980

7047

R53

ICD-10 Finland

Malaise and fatigue

1.5

26.5

969

6951

H01

ICPC

Ear pain/earache

1.7

26.5

528

3269

L50.2

ICD-10 Finland

Urticaria due to cold and heat

29.4

26.3

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

26.1

1238

9365

C07AB07

ATC

bisoprolol; oral

1.5

25.8

1371

10597

H02AB09

ATC

hydrocortisone; systemic

3.0

25.7

115

392

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.9

25.6

320

1718

R4110

NOMESCO Finland

Physiotherapy

1.5

25.5

928

6640

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.7

25.3

493

3031

R60.0

ICD-10 Finland

Localized oedema

1.8

25.0

404

2352

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.7

25.0

495

3055

S18

ICPC

Laceration/cut

1.4

24.9

1539

12214

N06AX21

ATC

duloxetine; oral

1.7

24.8

453

2735

M03BC01

ATC

orphenadrine (citrate); systemic

1.6

24.7

804

5607

L04AX03

ATC

methotrexate; systemic

1.9

24.6

351

1966

L50.5

ICD-10 Finland

Cholinergic urticaria

130.9

24.6

E000003, ,

ATC

2.4

24.6

179

779

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

24.5

761

5251

J46

ICD-10 Finland

Status asthmaticus

2.8

24.4

123

448

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.5

24.2

160

667

C03CA01

ATC

furosemide; systemic

1.6

24.1

745

5133

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.8

24.1

420

2499

K30

ICD-10 Finland

Functional dyspepsia

1.8

24.1

431

2585

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.7

24.1

520

3284

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.3

24.0

195

889

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

24.0

475

2930

R03AK08

ATC

formoterol and beclometasone; inhalant

2.3

24.0

180

794

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

23.9

1118

8401

M70.6

ICD-10 Finland

Trochanteric bursitis

1.7

23.8

459

2811

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

23.8

1129

8508

ZXE00

NOMESCO Finland

One hour or less

1.4

23.7

1334

10379

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.8

23.5

404

2394

D07AD01

ATC

clobetasol; topical

1.6

23.5

559

3618

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.9

23.5

328

1825

R06AX26

ATC

fexofenadine; oral

1.9

23.4

289

1543

N05CF01

ATC

zopiclone; oral

1.5

23.1

993

7330

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

23.0

842

6013

XG410

NOMESCO Finland

Flow-volume spirometry

2.5

23.0

142

573

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.7

22.6

482

3029

344

Kela drug reimbursment

Omalizumab

120.8

22.6

E000006, ,

ATC

2.0

22.6

243

1237

N02BF02

ATC

pregabalin; oral

2.0

22.2

257

1342

A03

ICPC

Fever

1.5

22.1

742

5195

WX002

NOMESCO Finland

Sedation and analgesia

1.6

22.1

584

3873

A02BC03

ATC

lansoprazole; oral

1.5

22.0

855

6174

L03

ICPC

Low back symptom/complaint

1.5

22.0

1094

8293

L04AD01

ATC

ciclosporin; systemic

3.3

22.0

256

R03BA08

ATC

ciclesonide; inhalant

1.8

21.8

319

1800

S06.0

ICD-10 Finland

Concussion

1.7

21.8

406

2461

UJF30

NOMESCO Finland

Ileoscopy through colon

1.8

21.7

355

2073

R03AC12

ATC

salmeterol; inhalant

2.4

21.4

149

636

L04AA01

ATC

[U] ciclosporin

4.1

21.4

147

N02AA05

ATC

oxycodone; systemic

1.6

21.1

496

3193

N06AX11

ATC

mirtazapine; oral

1.4

21.0

1176

9094

ZXD05

NOMESCO Finland

Urgent procedure

1.4

20.9

1012

7617

G47.3

ICD-10 Finland

Sleep apnoea

1.5

20.8

695

4854

M01AH05

ATC

etoricoxib; oral

1.4

20.6

2132

18270

D02AX

ATC

Other emollients and protectives

2.4

20.6

142

604

J31.0

ICD-10 Finland

Chronic rhinitis

1.8

20.5

333

1940

J05AB01

ATC

aciclovir; systemic

1.5

20.4

769

5506

WQ000

NOMESCO Finland

Hyposensibilisation

4.7

20.3

UKC02

NOMESCO Finland

Cystoscopy

1.7

20.3

394

2413

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.8

20.3

309

1765

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

19.8

1026

7805

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.6

19.8

473

3055

7089X

ICD-9 Finland

Urticaria, unspecified

+∞

19.8

M79.7

ICD-10 Finland

Fibromyalgia

2.3

19.7

153

685

G43.9

ICD-10 Finland

Migraine, unspecified

1.8

19.7

294

1668

M79.1

ICD-10 Finland

Myalgia

1.6

19.7

577

3913

R74

ICPC

Upper respiratory infection acute

1.4

19.6

1397

11227

R03DX05

ATC

omalizumab; parenteral

105.6

19.6

E000007, ,

ATC

2.0

19.4

212

1084

ZY010

NOMESCO Finland

Hospital outpatient

2.0

19.3

228

1198

J30.3

ICD-10 Finland

Other allergic rhinitis

2.2

19.3

168

788

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

19.3

1105

8551

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.8

19.3

309

1791

R03AC13

ATC

formoterol; inhalant

2.2

19.2

167

784

B01AB05

ATC

enoxaparin; parenteral

1.4

19.2

939

7064

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

19.1

303

1750

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.7

19.1

415

2616

M01AH01

ATC

celecoxib; oral

1.6

19.1

522

3481

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.0

19.1

201

1015

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.1

19.1

190

940

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

19.0

423

2685

J01FA15

ATC

telithromycin; oral

1.7

18.9

330

1960

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.5

18.9

116

467

R20.2

ICD-10 Finland

Paraesthesia of skin

1.8

18.8

271

1520

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

18.8

1960

16702

N30.9

ICD-10 Finland

Cystitis, unspecified

1.9

18.8

251

1375

H53.1

ICD-10 Finland

Subjective visual disturbances

1.9

18.7

256

1413

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.7

18.7

345

2082

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

18.7

460

2992

R55

ICD-10 Finland

Syncope and collapse

1.7

18.7

328

1953

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

18.6

1494

12213

L53.9

ICD-10 Finland

Erythematous condition, unspecified

4.2

18.6

118

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.9

18.5

227

1210

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

18.4

649

4573

R21

ICPC

Throat symptom/complaint

1.4

18.4

937

7093

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

18.4

214

1120

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

18.2

325

1942

R07.3

ICD-10 Finland

Other chest pain

1.7

18.2

348

2121

J01DA06

ATC

[U] cefuroxime

1.6

18.0

470

3098

J01DC02

ATC

cefuroxime; systemic

2.0

18.0

200

1029

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.4

17.9

986

7559

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.8

17.8

271

1547

A04

ICPC

Weakness/tiredness general

1.5

17.8

602

4206

M01AE02

ATC

naproxen; oral, rectal

1.4

17.8

2036

17539

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.7

17.7

331

2004

L12

ICPC

Hand/finger symptom/complaint

1.5

17.7

638

4516

R06.4

ICD-10 Finland

Hyperventilation

3.3

17.6

208

D01

ICPC

Abdominal pain/cramps general

1.6

17.6

503

3386

D11AH02

ATC

pimecrolimus; topical

5.3

17.5

H57.1

ICD-10 Finland

Ocular pain

2.1

17.5

170

834

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.9

17.3

233

1279

501

Kela drug reimbursment

Cow's milk and / or soy protein allergy in young children

3.4

17.2

176

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.4

17.2

123

532

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

17.2

2647

23806

R01AD05

ATC

budesonide; nasal

1.8

17.1

261

1490

A07AA02

ATC

nystatin; oral

2.1

17.0

173

862

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

17.0

1083

8497

D02

ICPC

Abdominal pain epigastric

1.8

17.0

244

1368

D11

ICPC

Diarrhoea

1.6

17.0

481

3230

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.6

17.0

375

2373

S21

ICPC

Skin texture symptom/complaint

1.5

17.0

511

3479

N05BA04

ATC

oxazepam; oral

1.4

16.9

879

6660

D02AE01

ATC

carbamide; topical

1.9

16.9

218

1180

D11AX14

ATC

[U] tacrolimus

5.4

16.8

XF600

NOMESCO Finland

Bloodpressure measurement

1.9

16.8

212

1140

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.7

16.8

308

1855

L23.5

ICD-10 Finland

Allergic contact dermatitis due to other chemical products

4.2

16.7

106

D09AB01

ATC

zinc bandage without supplements; topical

3.2

16.7

215

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

16.7

400

2582

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

16.6

450

2990

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

16.6

880

6689

L28

ICPC

Limited function/disability (L)

1.5

16.6

540

3738

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.6

16.5

470

3157

R06AE08, ,

ATC

4.1

16.5

107

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.1

16.5

162

798

L29.9

ICD-10 Finland

Pruritus, unspecified

2.4

16.4

116

500

ZXA05

NOMESCO Finland

Left side

1.5

16.3

674

4893

SPAT1254

SPAT

Administration of medicine

1.5

16.3

481

3259

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.6

16.3

443

2947

L02

ICPC

Back symptom/complaint

1.6

16.1

411

2691

M54.2

ICD-10 Finland

Cervicalgia

1.7

16.1

291

1746

A01AB09

ATC

miconazole; local oral

1.8

15.9

267

1569

Z00.0

ICD-10 Finland

General medical examination

1.5

15.8

651

4722

E66.01

ICD-10 Finland

Obesity due to excess calories

1.6

15.7

372

2392

D07BC01

ATC

betamethasone and antiseptics; topical

1.6

15.7

355

2258

A02BC04

ATC

rabeprazole; oral

1.7

15.7

296

1796

N05AH04

ATC

quetiapine; oral

1.5

15.7

640

4633

134

Kela drug reimbursment

General erythroderma

+∞

15.6

J01EA01

ATC

trimethoprim; systemic

1.4

15.6

868

6642

M01AB05

ATC

diclofenac; systemic, rectal

1.3

15.5

2166

19026

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

15.5

232

1316

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

2.1

15.5

140

667

R00.2

ICD-10 Finland

Palpitations

1.7

15.5

303

1855

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

15.5

1641

13863

A97

ICPC

No disease

1.4

15.5

715

5295

WZC30

NOMESCO Finland

Teaching

1.5

15.4

499

3446

N06AB10

ATC

escitalopram; oral

1.4

15.4

784

5907

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.1

15.4

138

657

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

15.3

772

5804

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

3.6

15.3

136

R4190

NOMESCO Finland

Nutritional therapy

2.0

15.3

162

820

R01AD11

ATC

triamcinolone; nasal

1.7

15.3

291

1771

N03AG01

ATC

valproic acid; systemic, rectal

1.9

15.2

206

1133

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

15.2

658

4811

Z2446

NOMESCO Finland

Social worker

1.8

15.1

244

1416

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.6

15.1

360

2318

M22.4

ICD-10 Finland

Chondromalacia patellae

2.2

15.1

124

570

ZX120

NOMESCO Finland

Intravenous

1.7

15.0

285

1731

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.1

15.0

146

716

R05

ICD-10 Finland

Cough

1.4

15.0

734

5487

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.6

15.0

327

2060

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.8

15.0

237

1368

J05AB11

ATC

valaciclovir; oral

1.5

14.9

489

3384

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

14.9

2677

24317

ZXD20

NOMESCO Finland

Day surgery

1.6

14.9

403

2675

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.6

14.9

421

2823

D10

ICPC

Vomiting

1.7

14.8

278

1686

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

14.7

471

3244

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.5

14.7

561

4005

J01

ICD-10 Finland

Acute sinusitis

1.8

14.7

232

1339

E66.8

ICD-10 Finland

Other obesity

1.8

14.6

216

1221

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.6

14.6

351

2264

K08.80

ICD-10 Finland

Toothache NOS

1.6

14.6

347

2232

M54

ICD-10 Finland

Dorsalgia

1.5

14.6

465

3197

P01BA02

ATC

hydroxychloroquine; oral

1.7

14.6

266

1598

M04AA01

ATC

allopurinol; systemic

1.7

14.6

283

1730

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.9

14.6

190

1033

K10.3

ICD-10 Finland

Alveolitis of jaws

1.9

14.5

196

1078

K02.1

ICD-10 Finland

Caries of dentine

1.3

14.5

2187

19332

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.7

14.5

253

1503

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.1

14.4

132

633

R09

ICPC

Sinus symptom/complaint

1.6

14.4

338

2169

R06.2

ICD-10 Finland

Wheezing

2.0

14.4

166

867

E66.9

ICD-10 Finland

Obesity, unspecified

2.1

14.4

144

715

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

14.4

543

3868

Z01.2

ICD-10 Finland

Dental examination

1.3

14.3

1754

15059

J01MA06

ATC

norfloxacin; oral

1.6

14.3

396

2640

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

14.3

1289

10610

L16

ICPC

Ankle symptom/complaint

1.5

14.3

447

3064

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

14.2

1877

16277

Y96.9

ICD-10 Finland

Unspecified type of accident

2.7

14.2

287

7806A

ICD-9 Finland

General symptoms, Pyrexia of unknown origin

4.2

14.1

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.9

14.1

185

1008

L04AX01

ATC

azathioprine; systemic

2.0

14.1

143

713

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.8

14.1

207

1169

J01DA09

ATC

[U] cefadroxil

1.4

14.1

855

6624

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.7

13.8

270

1655

L26

ICD-10 Finland

Exfoliative dermatitis

23.8

13.8

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.7

13.8

272

1671

R05FB02

ATC

cough suppressants and expectorants; systemic

1.3

13.7

1063

8547

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.8

13.7

204

1157

L01

ICPC

Neck symptom/complaint

1.4

13.7

601

4402

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

13.7

469

3275

K07.60

ICD-10 Finland

Snapping jaw

1.8

13.7

211

1210

T78.1

ICD-10 Finland

Other adverse food reactions, not elsewhere classified

12.1

13.6

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.5

13.5

427

2929

70890

ICD-8 Finland

Urticaria, Acuta

+∞

13.5

7088A

ICD-9 Finland

Urticaria, Other specified urticaria[URTICARIA CHRONICA NUD]

+∞

13.5

F45.8

ICD-10 Finland

Other somatoform disorders

1.7

13.5

284

1773

ZXA10

NOMESCO Finland

Bilateral

1.5

13.5

535

3843

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.5

13.5

419

2865

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

13.5

692

5209

WX290

NOMESCO Finland

Other blockage of nerve

1.3

13.5

1802

15608

N05BA01

ATC

diazepam; systemic, rectal

1.5

13.4

387

2603

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

3.7

13.4

115

S02

ICPC

Pruritus

2.0

13.4

146

747

A08

ICPC

Swelling

1.9

13.4

172

931

D11AX15

ATC

[U] pimecrolimus

6.1

13.4

N03AF02

ATC

oxcarbazepine; oral

2.2

13.3

114

533

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.9

13.3

175

955

Z00.8

ICD-10 Finland

Other general examinations

1.6

13.2

278

1736

N03AE01

ATC

clonazepam; systemic

1.9

13.2

171

929

L23.9

ICD-10 Finland

Allergic contact dermatitis, unspecified cause

3.5

13.2

131

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.5

13.1

422

2907

N03AX09

ATC

lamotrigine; oral

1.8

13.0

194

1100

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.7

13.0

232

1386

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.7

13.0

232

1386

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.9

13.0

159

848

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.9

12.9

165

892

A99

ICPC

Disease/condition unspecnature/site

1.6

12.9

341

2250

XF402

NOMESCO Finland

ECG with work load test

1.7

12.9

256

1575

J04BA02

ATC

dapsone; oral

5.0

12.9

D06

ICPC

Abdominal pain localized other

1.6

12.8

330

2164

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.9

12.8

163

880

K59.1

ICD-10 Finland

Functional diarrhoea

1.8

12.8

191

1085

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.5

12.8

460

3242

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.7

12.7

246

1502

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.9

12.7

156

832

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

12.7

273

1714

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

12.7

132

665

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

12.7

1297

10815

R03DC01

ATC

zafirlukast; oral

3.1

12.7

175

Z01.7

ICD-10 Finland

Laboratory examination

1.4

12.6

573

4216

K29

ICPC

Cardiovascular sympt/complt other

2.1

12.6

111

525

R01AD59

ATC

mometasone, combinations; nasal

1.6

12.6

279

1764

N03AX11

ATC

topiramate; oral

2.2

12.6

105

486

ZX112

NOMESCO Finland

Subcutaneous

2.6

12.5

282

WX320

NOMESCO Finland

Spinalanesthesy

1.4

12.5

713

5453

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.1

12.5

112

533

70891

ICD-8 Finland

Urticaria, Recidivans, Chronica

+∞

12.5

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.5

12.5

365

2462

R52.2

ICD-10 Finland

Other chronic pain

2.0

12.5

133

676

L01BA01

ATC

methotrexate; systemic

2.1

12.5

119

581

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.7

12.5

254

N89

ICPC

Migraine

1.8

12.4

176

983

C10AC01

ATC

colestyramine; oral

2.3

12.4

418

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.6

12.4

342

2277

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.7

12.4

224

1344

WX892

NOMESCO Finland

Monitored bed care

1.7

12.4

215

1276

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

12.3

648

4889

T63.4

ICD-10 Finland

Toxic effect: Venom of other arthropods

3.2

12.3

147

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.5

12.3

345

2307

U02

ICPC

Urinary frequency/urgency

1.4

12.2

504

3643

A04AA01

ATC

ondansetron; systemic, rectal

1.7

12.2

254

1581

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.7

12.1

232

1413

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

12.1

548

4030

T82

ICPC

Obesity

1.9

12.1

162

890

NF1AA

NOMESCO Finland

Hip X-ray examination

1.7

12.1

228

1384

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

12.1

205

1209

SFA20

NOMESCO Finland

Two-surface restoration

1.3

12.1

2079

18487

P06

ICPC

Sleep disturbance

1.5

12.0

464

3311

R31

ICD-10 Finland

Unspecified haematuria

1.7

12.0

239

1471

S97

ICPC

Chronic ulcer skin

1.9

12.0

159

870

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.8

12.0

182

1039

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.6

11.9

269

1709

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.7

11.9

198

1160

R5140

NOMESCO Finland

Monitoring the use of the aid

1.6

11.9

300

1957

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.6

11.9

253

1585

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.0

11.9

126

640

R51

ICD-10 Finland

Headache

1.7

11.8

220

1330

TQW80

NOMESCO Finland

Local dermatologic skincare

2.4

11.8

345

N02BF01

ATC

gabapentin; oral

1.5

11.8

328

2187

L52

ICD-10 Finland

Erythema nodosum

5.4

11.8

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

3.1

11.8

151

L13

ICPC

Hip symptom/complaint

1.4

11.8

564

4187

R52.0

ICD-10 Finland

Acute pain

2.0

11.8

129

663

C03DA01

ATC

spironolactone; oral

1.6

11.7

307

2020

M02AA07

ATC

piroxicam; topical

1.3

11.7

982

7951

R83

ICPC

Respiratory infection other

1.3

11.7

1022

8322

GD1AA, ,

SPAT

1.4

11.7

588

4402

N06AX16

ATC

venlafaxine; oral

1.4

11.6

504

3675

H92.0

ICD-10 Finland

Otalgia

1.6

11.6

252

1586

J02AC02

ATC

itraconazole; systemic

1.4

11.6

523

3841

W19

ICD-10 Finland

Unspecified fall

1.6

11.6

300

1970

C09CA06

ATC

candesartan; oral

1.4

11.6

709

5480

XQ818

NOMESCO Finland

Conjunctival allergen provocation test

19.0

11.6

SFA10

NOMESCO Finland

One-surface restoration

1.3

11.6

1976

17511

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

11.6

547

4052

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

3.9

11.5

R12

ICD-10 Finland

Heartburn

1.6

11.5

289

1884

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.6

11.5

259

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

5.0

11.5

R35

ICD-10 Finland

Polyuria

1.8

11.4

177

1016

C08CA05

ATC

nifedipine; systemic

1.9

11.4

152

833

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.4

11.4

326

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.7

11.4

222

1359

V700A

ICD-9 Finland

General medical examination, Routine general medical examination at a health care facility

2.4

11.4

314

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.2

11.4

467

Z2445

NOMESCO Finland

Psychologist

1.8

11.3

157

872

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.8

11.3

166

938

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.0

11.3

127

658

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.5

11.3

387

2698

SPAT1263

SPAT

Sampling

1.3

11.3

1381

11742

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.1

11.2

108

529

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.9

11.2

145

788

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

1.8

11.2

161

905

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

11.1

1037

8508

A11

ICPC

Chest pain NOS

1.6

11.1

250

1587

B01AB04

ATC

dalteparin; parenteral

1.9

11.1

148

812

ZXA00

NOMESCO Finland

Right side

1.4

11.1

698

5414

K59.0

ICD-10 Finland

Constipation

1.8

11.1

173

996

R4120

NOMESCO Finland

Occupational therapy

1.7

11.1

208

1261

H03AA01

ATC

levothyroxine sodium; systemic

1.3

11.1

735

5747

W57

ICD-10 Finland

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

2.0

11.1

126

656

UJD02

NOMESCO Finland

Gastroscopy

1.9

11.0

129

678

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.6

11.0

275

1790

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.4

11.0

301

6918B

ICD-9 Finland

Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]

3.1

11.0

142

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.8

11.0

154

859

N06AB04

ATC

citalopram; systemic

1.4

11.0

630

4817

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.6

10.9

232

1452

N01

ICPC

Headache

1.4

10.9

495

3637

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.5

10.9

324

2195

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.9

10.9

138

746

Y89.9

ICD-10 Finland

Sequelae of unspecified external cause

3.1

10.8

143

L23.2

ICD-10 Finland

Allergic contact dermatitis due to cosmetics

3.1

10.8

138

R06AX18

ATC

acrivastine; oral

2.2

10.8

404

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.9

10.8

139

754

J11.1

ICD-10 Finland

Influenza with other respiratory manifestations, virus not identified

2.2

10.8

385

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.7

10.8

221

1371

T90

ICPC

Diabetes non-insulin dependent

1.4

10.8

596

4528

N05CF02

ATC

zolpidem; oral

1.4

10.7

531

3962

JAH01

NOMESCO Finland

Laparoscopy

1.8

10.7

151

844

M81.4

ICD-10 Finland

Drug-induced osteoporosis

5.6

10.7

K04.1

ICD-10 Finland

Necrosis of pulp

1.5

10.7

362

2518

A85

ICPC

Adverse effect medical agent

3.0

10.6

150

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

10.6

1574

13665

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.7

10.5

212

1309

SGA01

NOMESCO Finland

Emergency treatment

1.4

10.5

563

4252

R03DA04

ATC

theophylline; systemic, rectal

1.9

10.5

126

668

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.0

10.5

107

536

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.7

10.5

178

1050

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

10.5

709

5555

M10.9

ICD-10 Finland

Gout, unspecified

1.8

10.5

147

820

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

10.5

842

6764

S01GX05

ATC

lodoxamide; ophthalmic

2.8

10.4

179

7088B

ICD-9 Finland

Urticaria, Other specified urticaria[URTICARIA RECURRENS NUD]

+∞

10.4

JN4AD

NOMESCO Finland

Body CT examination

1.6

10.4

280

1854

D07CC01

ATC

betamethasone and antibiotics; topical

1.5

10.4

378

2667

S92.5

ICD-10 Finland

Fracture of other toe

2.0

10.3

108

546

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.7

10.3

196

1192

XQ810

NOMESCO Finland

Physical test for urticaria

32.6

10.3

L04

ICPC

Chest symptom/complaint

1.7

10.3

210

1301

ZXX03

NOMESCO Finland

Extent of procedure, 3 units

4.3

10.3

C10AA07

ATC

rosuvastatin; oral

1.3

10.3

899

7302

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.7

10.2

168

982

R01AD01

ATC

beclometasone; nasal

1.4

10.2

469

3452

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.8

10.2

159

916

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

2.1

10.2

481

A28

ICPC

Limited function/disability NOS

1.4

10.2

426

3084

SPAT1260

SPAT

Consultation of another employee

1.4

10.2

527

3960

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

1.9

10.1

121

641

N03AF01

ATC

carbamazepine; oral, rectal

1.9

10.1

134

734

K29.1

ICD-10 Finland

Other acute gastritis

3.0

10.1

149

Y59

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified vaccines and biological substances

3.4

10.1

103

M89.0

ICD-10 Finland

Algoneurodystrophy

3.2

10.1

118

SPAT1283

SPAT

Restricted health certificate

1.3

10.1

711

5600

Z50.1

ICD-10 Finland

Other physical therapy

1.8

10.1

149

844

M48.0

ICD-10 Finland

Spinal stenosis

1.5

10.1

287

1924

L86

ICPC

Back syndrome with radiating pain

1.7

10.1

192

1169

U05

ICPC

Urination problems other

1.8

10.1

141

786

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

10.1

190

1154

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.3

10.1

798

6392

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.7

10.1

187

1131

C07AA05

ATC

propranolol; systemic

1.3

10.0

686

5380

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.9

10.0

118

622

C08CA01

ATC

amlodipine; oral

1.3

10.0

939

7693

XQ830

NOMESCO Finland

Exposure to foodstuff

9.1

10.0

S71

ICPC

Herpes simplex

3.2

10.0

119

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.0

10.0

103

519

L08

ICPC

Shoulder symptom/complaint

1.3

10.0

701

5520

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.0

10.0

485

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.9

10.0

129

702

A06AD11

ATC

lactulose; oral

1.5

10.0

366

2586

D07XC01

ATC

betamethasone; topical

1.5

9.9

323

2229

M13.9

ICD-10 Finland

Arthritis, unspecified

1.6

9.9

223

1418

H66.9

ICD-10 Finland

Otitis media, unspecified

1.5

9.9

284

1909

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

9.9

816

6573

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.1

9.9

420

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

2.6

9.8

202

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.7

9.8

179

1078

R03AA01

ATC

epinephrine; inhalant

26.1

9.8

D06AX01

ATC

fusidic acid; topical

1.5

9.8

298

2027

WX402

NOMESCO Finland

General anaesthesia

1.3

9.8

722

5725

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

1.7

9.7

171

1019

B02.9

ICD-10 Finland

Zoster without complication

1.7

9.7

193

1188

TNG10

NOMESCO Finland

Puncture of knee

2.9

9.7

158

A02BA04

ATC

nizatidine; systemic

1.7

9.7

179

1081

S01GX08

ATC

ketotifen; ophthalmic

1.7

9.7

172

1028

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.5

9.7

279

1876

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

9.7

800

6443

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.3

9.7

729

5797

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.6

9.6

239

1555

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

2.2

9.6

352

R2110

NOMESCO Finland

Giving the first information

1.6

9.6

220

1404

S04

ICPC

Lump/swelling localized

1.4

9.6

383

2748

B01AA03

ATC

warfarin; systemic

1.4

9.6

375

2681

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.5

9.6

320

2219

F01

ICPC

Eye pain

1.9

9.6

110

576

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

9.6

604

4680

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.1

9.6

412

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.3

9.5

302

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

9.5

176

1063

A10BJ02

ATC

liraglutide; parenteral

2.1

9.5

439

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

9.5

313

2163

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

2.5

9.5

223

L29

ICPC

Musculoskeletal sympt/complt other

1.5

9.5

282

1909

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.8

9.5

140

794

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.5

9.5

326

2274

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

1.8

9.5

144

824

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.6

9.5

245

1609

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.8

9.4

127

700

N17

ICPC

Vertigo/dizziness

1.4

9.4

385

2774

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.4

9.4

394

2851

L23.0

ICD-10 Finland

Allergic contact dermatitis due to metals

3.0

9.4

134

L50.60

ICD-10 Finland

Allergic contact urticaria

17.6

9.4

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

9.4

345

2439

E86

ICD-10 Finland

Volume depletion

2.3

9.3

280

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.5

9.3

289

1974

M23.8

ICD-10 Finland

Other internal derangements of knee

1.8

9.3

125

689

S76

ICPC

Skin infection other

1.7

9.3

159

942

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.0

9.3

478

XKD00

NOMESCO Finland

Uroflowmetry

1.5

9.3

278

1886

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.7

9.3

155

912

K04.0

ICD-10 Finland

Pulpitis

1.5

9.2

321

2243

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

1.9

9.2

110

583

S01GX02

ATC

levocabastine; ophthalmic

1.6

9.2

196

1228

N03AX14

ATC

levetiracetam; systemic

2.1

9.2

418

R75

ICPC

Sinusitis acute/chronic

1.7

9.2

179

1098

KCV04

NOMESCO Finland

Distension of bladder with fluid

3.4

9.2

R25.2

ICD-10 Finland

Cramp and spasm

2.2

9.1

366

XF404

NOMESCO Finland

Ambulatory ECG

1.6

9.1

217

1399

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.7

9.1

179

1101

R81

ICPC

Pneumonia

1.9

9.1

113

608

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

1.7

9.1

146

850

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

2.0

9.1

496

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.2

9.1

348

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.5

9.0

245

1626

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

9.0

362

2600

ACC51

NOMESCO Finland

Release of median nerve

1.6

9.0

222

1442

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.7

9.0

166

1003

J04.0

ICD-10 Finland

Acute laryngitis

1.7

9.0

158

943

U72

ICPC

Urethritis

2.1

8.9

416

N07BA03

ATC

varenicline; oral

1.7

8.9

149

876

F29

ICPC

Eye symptom/complaint other

1.4

8.9

346

2469

XQ832

NOMESCO Finland

Other provocation test

18.6

8.9

N06AA09

ATC

amitriptyline; systemic

1.5

8.9

246

1639

R05FA02

ATC

opium derivatives and expectorants; systemic

1.3

8.9

1204

10286

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

1.8

8.9

132

751

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.3

8.9

653

5169

GD1AD

NOMESCO Finland

Thorax CT examination

1.7

8.9

156

931

A03FA02

ATC

cisapride; oral, rectal

1.6

8.8

192

1210

R03BB07

ATC

umeclidinium bromide; inhalant

3.6

8.8

I80.9

ICD-10 Finland

Phlebitis and thrombophlebitis of unspecified site

2.7

8.8

173

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

2.6

8.8

179

N02AC04

ATC

dextropropoxyphene; oral

2.1

8.8

386

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

2.4

8.7

251

R01AC01

ATC

cromoglicic acid; nasal

1.8

8.7

139

807

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

1.9

8.7

104

552

A01AB04

ATC

amphotericin B; local oral

1.8

8.7

116

638

L20

ICPC

Joint symptom/complaint NOS

1.8

8.7

125

704

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.4

8.7

347

2491

S80.0

ICD-10 Finland

Contusion of knee

1.5

8.7

264

1797

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.5

8.7

258

1748

M01AH02

ATC

rofecoxib; oral

1.5

8.6

304

2130

N06AA10

ATC

nortriptyline; systemic

2.2

8.6

303

ZYC01

NOMESCO Finland

Remote contact by phone

1.6

8.6

202

1297

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.3

8.6

607

4775

L04AA24

ATC

abatacept; parenteral

4.0

8.6

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.7

8.6

160

970

F41.00

ICD-10 Finland

Moderate panic disorder

2.2

8.6

304

L15

ICPC

Knee symptom/complaint

1.3

8.6

792

6461

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.6

8.5

173

1072

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

2.3

8.5

279

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.0

8.5

459

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

1.7

8.5

156

943

F43.1

ICD-10 Finland

Post-traumatic stress disorder

1.8

8.5

119

666

SPAT1312

SPAT

General health counselling

1.3

8.4

1056

8931

F17.20

ICD-10 Finland

Addiction relationship caused by tobacco addiction relationship currently independent

3.7

8.4

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.5

8.4

229

1521

KMAK, ,

NOMESCO Finland

1.2

8.4

1728

15407

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.0

8.4

481

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

8.4

2502

23177

N06AX12

ATC

bupropion; oral

1.5

8.4

274

1891

L20.8

ICD-10 Finland

Other atopic dermatitis

2.6

8.4

183

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

2.2

8.4

294

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

1.6

8.4

171

1062

D72.1

ICD-10 Finland

Eosinophilia

4.5

8.4

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

4.5

8.4

H01.0

ICD-10 Finland

Blepharitis

1.5

8.4

242

1630

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

3.2

8.3

S01

ICPC

Pain/tenderness of skin

1.7

8.3

147

879

R13

ICD-10 Finland

Dysphagia

1.6

8.3

192

1229

R03BB01

ATC

ipratropium bromide; inhalant

2.0

8.3

428

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.2

8.3

302

M77.1

ICD-10 Finland

Lateral epicondylitis

1.5

8.2

259

1775

H60.8

ICD-10 Finland

Other otitis externa

1.9

8.2

103

556

A10BJ06

ATC

semaglutide; parenteral

1.7

8.2

150

905

M02AA10

ATC

ketoprofen; topical

1.4

8.2

428

3215

R60.1

ICD-10 Finland

Generalized oedema

3.3

8.2

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.7

8.2

147

883

H29

ICPC

Ear symptom/complaint other

1.4

8.2

361

2637

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.8

8.2

121

688

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

1.9

8.2

101

543

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.4

8.1

302

2138

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.4

8.1

301

2131

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.6

8.1

186

1189

S01GX09

ATC

olopatadine; ophthalmic

1.9

8.1

100

538

SFA30

NOMESCO Finland

Three-surface restoration

1.2

8.1

1304

11330

OAB50, ,

SPAT

1.5

8.1

214

1415

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

8.1

150

910

Y88.0

ICD-10 Finland

Sequelae of adverse effects caused by drugs, medicaments and biological substances in therapeutic use

6.8

8.1

A77

ICPC

Viral disease other/NOS

1.7

8.0

129

751

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.6

8.0

166

1034

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

1.9

8.0

101

546

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

2.0

8.0

406

S89.9

ICD-10 Finland

Unspecified injury of lower leg

1.8

8.0

121

692

SXC02

NOMESCO Finland

Other oral or dental procedure, restricted

2.0

8.0

448

C08CA13

ATC

lercanidipine; oral

1.4

8.0

339

2459

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.8

8.0

120

686

C09AA05

ATC

ramipril; oral

1.3

8.0

539

4212

S87

ICPC

Dermatitis/atopic eczema

1.9

8.0

505

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

1.7

7.9

137

814

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.2

7.9

282

SPAT1211

SPAT

Application of soft bandage

1.5

7.9

254

1749

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

2.8

7.9

137

P25

ICPC

Phase of life problem adult

1.6

7.9

167

1047

EBA00

NOMESCO Finland

Extraction of tooth

1.2

7.9

1232

10659

U07

ICPC

Urine symptom/complaint other

1.5

7.9

241

1642

R4110, ,

SPAT

1.4

7.9

377

2792

R51.81

ICD-10 Finland

Facial pain NOS

2.0

7.9

423

L20

ICD-10 Finland

Atopic dermatitis

1.7

7.9

127

741

NB6AA

NOMESCO Finland

Humerus X-ray examination

2.2

7.9

302

K11.88

ICD-10 Finland

Other diseases of salivary glands

7.8

7.9

B02AA02

ATC

tranexamic acid; systemic

1.3

7.9

480

3695

D05AX52

ATC

calcipotriol, combinations; topical

1.7

7.9

139

832

D07AC14

ATC

methylprednisolone aceponate; topical

1.7

7.8

137

817

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.8

7.8

113

638

S63.5

ICD-10 Finland

Sprain and strain of wrist

1.7

7.8

141

848

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.4

7.8

341

2487

H10

ICD-10 Finland

Conjunctivitis

1.5

7.8

273

1912

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.6

7.8

175

1114

P03

ICPC

Feeling depressed

1.4

7.8

405

3042

EB1VA, ,

NOMESCO Finland

1.3

7.8

572

4523

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

1.9

7.8

460

395

Kela drug reimbursment

Dupilumab

6.9

7.8

W79

ICD-10 Finland

Inhalation and ingestion of food causing obstruction of respiratory tract

6.9

7.8

SPAT1310

SPAT

Counselling related to known health issue

1.2

7.8

988

8359

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.6

7.8

166

1044

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

1.7

7.7

130

767

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

1.9

7.7

517

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.5

7.7

246

1690

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.9

7.7

503

C09CA01

ATC

losartan; oral

1.3

7.7

624

4996

G43

ICD-10 Finland

Migraine

1.5

7.7

223

1502

R32

ICD-10 Finland

Unspecified urinary incontinence

2.0

7.7

378

K03.00

ICD-10 Finland

Approximal wear

1.5

7.7

256

1775

Z3229

NOMESCO Finland

Other healthcare associate professional

1.5

7.7

222

1496

N29

ICPC

Neurological sympt/complt other

2.3

7.7

260

NGF00

NOMESCO Finland

Excision of plica of synovy of knee

2.2

7.7

299

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.3

7.6

542

4263

J01CA04

ATC

amoxicillin; systemic

1.3

7.6

2980

28252

P01

ICPC

Feeling anxious/nervous/tense

1.3

7.6

556

4390

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.6

7.6

159

994

L30.0

ICD-10 Finland

Nummular dermatitis

1.8

7.6

108

607

M54.6

ICD-10 Finland

Pain in thoracic spine

1.5

7.6

242

1663

I50.0

ICD-10 Finland

Congestive heart failure

1.7

7.6

138

832

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.1

7.6

353

K07

ICPC

Swollen ankles/oedema

1.8

7.6

115

659

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.5

7.6

247

1705

L04AB04

ATC

adalimumab; parenteral

2.0

7.6

401

N02CC05

ATC

almotriptan; oral

1.7

7.6

134

802

M01AX17

ATC

nimesulide; oral

1.3

7.6

582

4627

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

1.9

7.6

478

M77.4

ICD-10 Finland

Metatarsalgia

1.5

7.6

199

1313

Y94.0

ICD-10 Finland

Accident at home

2.3

7.6

255

AB5CT

NOMESCO Finland

Blockage of nerv root with CT guidance

3.1

7.6

102

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

1.9

7.6

521

L51.9

ICD-10 Finland

Erythema multiforme, unspecified

10.0

7.5

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.6

7.5

182

1179

I45.9

ICD-10 Finland

Conduction disorder, unspecified

3.2

7.5

103

Kela drug reimbursment

Diabetes, insulin-treated

1.3

7.5

636

5123

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.3

7.5

462

3562

N73.9

ICD-10 Finland

Female pelvic inflammatory disease, unspecified

2.1

7.5

302

SPAT1097

SPAT

Recording of ECG

1.4

7.5

343

2524

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.5

7.4

205

1367

B03XA02

ATC

darbepoetin alfa; parenteral

2.3

7.4

238

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.6

7.4

146

899

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

7.4

1296

11326

3DX05, ,

NOMESCO Finland

80.3

7.4

L04AA13

ATC

[U] leflunomide

2.1

7.4

343

G04CA02

ATC

tamsulosin; oral

1.4

7.4

372

2777

R23.3

ICD-10 Finland

Spontaneous ecchymoses

2.1

7.4

303

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.7

7.4

135

815

N06AB06

ATC

sertraline; oral

1.4

7.4

390

2934

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.4

7.4

381

2856

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

7.4

350

2588

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

2.1

7.4

330

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

7.4

1381

12150

N05

ICPC

Tingling fingers/feet/toes

2.7

7.4

148

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.6

7.4

161

1018

ZX108

NOMESCO Finland

Inhalation

3.3

7.4

R03CC02

ATC

salbutamol; systemic

1.5

7.3

253

1767

G40.9

ICD-10 Finland

Epilepsy, unspecified

1.9

7.3

505

L09

ICPC

Arm symptom/complaint

1.6

7.3

165

1051

A60

ICPC

General and Unspecified, Result test/procedure

1.7

7.3

129

772

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.5

7.3

206

1381

S06

ICPC

Rash localized

1.6

7.3

165

1052

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.5

7.3

196

1301

1220

FHL

Arthroscopy

1.8

7.3

528

M54.1

ICD-10 Finland

Radiculopathy

1.8

7.3

113

653

OAB93, ,

SPAT

1.5

7.3

256

1796

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

1.8

7.2

101

565

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

2.2

7.2

260

A07AA09

ATC

vancomycin; oral

2.5

7.2

167

XG405

NOMESCO Finland

Education on PEF monitoring

2.4

7.2

185

R04.2

ICD-10 Finland

Haemoptysis

2.0

7.2

381

R33

ICD-10 Finland

Retention of urine

1.6

7.2

153

961

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.5

7.2

221

1508

WVA20

NOMESCO Finland

Medicine administration

1.9

7.2

444

U01

ICPC

Dysuria/painful urination

1.4

7.2

274

1950

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

1.9

7.2

437

R06AX12

ATC

terfenadine; oral

1.7

7.2

138

845

UDM02

NOMESCO Finland

Sinoscopy

2.1

7.2

327

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.5

7.2

214

1452

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.4

7.2

398

3019

WZC00, ,

SPAT

1.3

7.2

481

3753

R05DA01

ATC

ethylmorphine; oral

1.5

7.2

205

1379

K60.2

ICD-10 Finland

Anal fissure, unspecified

2.2

7.2

281

I50.9

ICD-10 Finland

Heart failure, unspecified

1.4

7.1

262

1852

A23

ICPC

Risk factor NOS

1.4

7.1

343

2543

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

1.8

7.1

503

A10AB05

ATC

insulin aspart; parenteral

1.5

7.1

205

1381

R03AK11

ATC

formoterol and fluticasone; inhalant

2.0

7.1

383

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.6

7.1

158

1004

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

1.8

7.1

109

628

E87.5

ICD-10 Finland

Hyperkalaemia

2.5

7.1

175

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.4

7.1

257

1814

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.4

7.1

313

2289

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

7.1

383

2895

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

2.9

7.0

112

A10BK03

ATC

empagliflozin; oral

1.5

7.0

244

1706

B34.9

ICD-10 Finland

Viral infection, unspecified

1.8

7.0

108

622

G43.3

ICD-10 Finland

Complicated migraine

2.0

7.0

364

D19

ICPC

Teeth/gum symptom/complaint

1.2

7.0

1072

9232

K85

ICPC

Elevated blood pressure

1.3

7.0

416

3188

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.2

7.0

264

L18

ICPC

Muscle pain

1.7

7.0

133

813

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.6

7.0

141

875

XW000

NOMESCO Finland

Bone marrow biopsy

1.8

7.0

543

F41

ICD-10 Finland

Other anxiety disorders

2.0

7.0

386

G03DC03

ATC

lynestrenol; oral

1.9

7.0

407

XA800

NOMESCO Finland

Neuropsychological investigation

1.7

7.0

124

745

S60.0

ICD-10 Finland

Contusion of finger(s) without damage to nail

1.7

7.0

127

768

JN4BD

NOMESCO Finland

Extensive body CT

1.5

6.9

230

1594

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

2.1

6.9

318

A10BH01

ATC

sitagliptin; oral

1.5

6.9

206

1397

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

1.7

6.9

111

648

D11AH05

ATC

dupilumab; topical

5.8

6.9

D09

ICPC

Nausea

1.5

6.9

185

1228

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.0

6.9

360

A03CA02

ATC

clidinium and psycholeptics; oral

1.7

6.9

129

786

D69.0

ICD-10 Finland

Allergic purpura

3.2

6.8

Y34

ICD-10 Finland

Unspecified event, undetermined intent

3.2

6.8

D64.9

ICD-10 Finland

Anaemia, unspecified

1.5

6.8

243

1708

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.8

6.8

104

598

A02BD02

ATC

lansoprazole, tetracycline and metronidazole; systemic

2.2

6.8

267

K02.0

ICD-10 Finland

Caries limited to enamel

1.3

6.8

769

6408

NGE10

NOMESCO Finland

Incision or suture of capsule of knee joint

3.0

6.8

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.6

6.8

149

944

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

1.6

6.8

150

952

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

1.9

6.8

411

K04.08

ICD-10 Finland

Other specified pulpit

1.4

6.8

273

1964

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.3

6.8

449

3497

A06AC51

ATC

ispaghula, combinations; oral

1.7

6.8

127

774

M01AB55

ATC

diclofenac, combinations; oral

1.6

6.8

153

977

XA402

NOMESCO Finland

ENMG

2.0

6.8

335

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

1.8

6.8

490

DHB50

NOMESCO Finland

Turbinoplasty

1.9

6.7

440

W10

ICD-10 Finland

Fall on and from stairs and steps

1.6

6.7

149

946

G43.8

ICD-10 Finland

Other migraine

2.0

6.7

329

R97

ICPC

Allergic rhinitis

1.9

6.7

441

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.4

6.7

267

1917

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.6

6.7

157

1011

T78.9

ICD-10 Finland

Adverse effect, unspecified

22.5

6.7

W05

ICPC

Pregnancy vomiting/nausea

2.3

6.7

205

C10AA05

ATC

atorvastatin; oral

1.2

6.7

992

8512

Z01.9

ICD-10 Finland

Special examination, unspecified

1.6

6.7

168

1100

WZA90

NOMESCO Finland

Other medical or dental certificate

1.2

6.6

760

6339

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.4

6.6

251

1785

NK4AT

NOMESCO Finland

Puncture of joint with ultrasound guidance not elsewher classified

2.8

6.6

116

X50

ICD-10 Finland

Overexertion and strenuous or repetitive movements

2.1

6.6

290

N06AG02

ATC

moclobemide; oral

1.7

6.6

107

626

M01AX01

ATC

nabumetone; oral

1.8

6.6

559

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.4

6.6

265

1904

H60

ICD-10 Finland

Otitis externa

1.5

6.6

176

1166

A10BA02

ATC

metformin; oral

1.3

6.6

683

5633

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

2.5

6.6

157

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.0

6.6

311

N80.9

ICD-10 Finland

Endometriosis, unspecified

1.9

6.6

458

N80.0

ICD-10 Finland

Endometriosis of uterus

1.9

6.6

387

A10AE04

ATC

insulin glargine; parenteral

1.4

6.6

236

1662

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

2.9

6.6

100

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.4

6.6

326

2430

R43

ICPC

Respiratory, Other diagnostic procedure

3.2

6.6

R68.2

ICD-10 Finland

Dry mouth, unspecified

3.2

6.6

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.8

6.6

502

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.4

6.5

279

2027

K29.3

ICD-10 Finland

Chronic superficial gastritis

1.9

6.5

416

U71

ICPC

Cystitis/urinary infection other

1.5

6.5

218

1514

J01DA08

ATC

[U] cefaclor

1.3

6.5

418

3239

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

6.5

460

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.6

6.5

148

947

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

3.0

6.5

K04

ICPC

Palpitations/awareness of heart

1.6

6.5

163

1067

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.7

6.5

121

737

N06AX03

ATC

mianserin; oral

1.7

6.5

121

737

D05BB02

ATC

acitretin; oral

2.2

6.5

253

N06AB03

ATC

fluoxetine; oral

1.3

6.5

366

2785

E66.00

ICD-10 Finland

Metabolic syndrome

1.6

6.5

151

972

N06AX22

ATC

agomelatine; oral

1.8

6.5

461

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.0

6.5

334

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

1.8

6.5

512

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

1.6

6.4

136

854

N05CD07

ATC

temazepam; oral

1.4

6.4

245

1744

N30

ICD-10 Finland

Cystitis

1.4

6.4

285

2084

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.4

6.4

257

1846

J34.2

ICD-10 Finland

Deviated nasal septum

1.6

6.4

139

878

F50.2

ICD-10 Finland

Bulimia nervosa

2.7

6.4

118

L27.1

ICD-10 Finland

Localized skin eruption due to drugs and medicaments

3.5

6.4

L51.10

ICD-10 Finland

Stevens-Johnson syndrome

70.0

6.4

XCK00

NOMESCO Finland

Perimetry

1.6

6.4

142

902

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

2.2

6.4

215

SPAT1139

SPAT

Nutrition survey

1.8

6.4

491

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

1.7

6.4

103

602

RD210, ,

NOMESCO Finland

2.0

6.4

328

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.7

6.4

122

747

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

6.4

297

2190

M54.8

ICD-10 Finland

Other dorsalgia

1.6

6.4

144

919

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

2.0

6.4

356

A29

ICPC

General symptom/complaint other

1.3

6.4

381

2922

E66

ICD-10 Finland

Obesity

1.5

6.4

185

1249

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

1.6

6.4

139

880

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

1.6

6.4

141

896

H02BX01

ATC

methylprednisolone, combinations; systemic

1.7

6.4

108

641

SDA03

NOMESCO Finland

Periodontal treatment

1.2

6.4

1374

12209

L30.3

ICD-10 Finland

Infective dermatitis

1.7

6.3

574

4659X

ICD-9 Finland

Acute upper respiratory infections of multiple or unspecified sites, Unspecified site

2.1

6.3

275

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.1

6.3

262

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

2.1

6.3

289

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

1.9

6.3

407

S20.2

ICD-10 Finland

Contusion of thorax

1.6

6.3

145

930

T93.3

ICD-10 Finland

Sequelae of dislocation, sprain and strain of lower limb

2.9

6.3

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.4

6.3

274

1998

J37.0

ICD-10 Finland

Chronic laryngitis

1.8

6.3

494

F43.9

ICD-10 Finland

Reaction to severe stress, unspecified

1.7

6.3

109

651

J01CF05

ATC

flucloxacillin; systemic

1.5

6.3

209

1451

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.6

6.3

145

931

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

2.7

6.3

114

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

2.2

6.3

211

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.7

6.3

104

614

A12

ICPC

ALLERGY/ALLERGIC REACTION

3.8

6.3

69598

ICD-8 Finland

Erythematous condition, Alii definiti

+∞

6.2

H71

ICPC

Acute otitis media/myringitis

2.2

6.2

237

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

1.6

6.2

120

737

A27

ICPC

Fear of other disease NOS

1.6

6.2

143

917

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.0

6.2

311

A07EC01

ATC

sulfasalazine; oral, rectal

1.4

6.2

220

1546

G50.0

ICD-10 Finland

Trigeminal neuralgia

2.1

6.2

264

H53.2

ICD-10 Finland

Diplopia

1.8

6.2

467

D29

ICPC

Digestive symptom/complaint other

1.9

6.2

431

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.6

6.2

129

808

KH1AD

NOMESCO Finland

CT of urinary organs

1.8

6.2

504

PA7BD

NOMESCO Finland

CT angiography of neck and brain

2.4

6.2

162

B03BA03

ATC

hydroxocobalamin; parenteral

1.6

6.2

122

754

J06

ICD-10 Finland

Acute upper respiratory infections of multiple and unspecified sites

1.5

6.2

165

1095

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

1.9

6.2

375

WW500

NOMESCO Finland

Blood transfusion

1.7

6.2

104

617

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.1

6.1

252

C10AX09

ATC

ezetimibe; oral

1.3

6.1

382

2948

49302

ICD-8 Finland

Asthma, Rhinitis allergica cum asthmate bronchiali

3.3

6.1

M54.3

ICD-10 Finland

Sciatica

1.5

6.1

161

1065

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

2.0

6.1

313

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.5

6.1

215

1509

R15

ICD-10 Finland

Faecal incontinence

1.8

6.1

433

B07.9

ICD-10 Finland

Verruca simplex

1.6

6.1

119

733

J01.4

ICD-10 Finland

Acute pansinusitis

2.7

6.1

110

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.3

6.1

366

2809

UDC00

NOMESCO Finland

Ear microscopy

1.5

6.1

203

1410

DM1AA, ,

SPAT

2.0

6.1

307

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

2.3

6.1

182

LCA06

NOMESCO Finland

Biopsy of endometrium

1.3

6.1

352

2688

N02AJ13

ATC

tramadol and paracetamol; systemic

1.9

6.1

342

Z71.9

ICD-10 Finland

Counselling, unspecified

1.4

6.0

245

1765

N76.0

ICD-10 Finland

Acute vaginitis

1.4

6.0

268

1961

L04AA06

ATC

mycophenolic acid; systemic

2.1

6.0

267

WX213

NOMESCO Finland

Lower leg blockade

2.9

6.0

J03

ICD-10 Finland

Acute tonsillitis

1.7

6.0

105

628

XG460

NOMESCO Finland

Short time oxymetry

2.4

6.0

158

R49.01

ICD-10 Finland

Functional dysphonia

1.8

6.0

501

H57.9

ICD-10 Finland

Disorder of eye and adnexa, unspecified

2.4

6.0

152

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3019420) Tryptase [Mass/volume] in Serum or Plasma

180

158

11.92

175.02

1.4

1.5

5.15

7.06

ug/l

1.41

171

138

(3005322) IgE [Units/volume] in Serum or Plasma

687

2513

3.12

140.78

1.6

1.3

376.79

228.86

u/ml

1.51

653

2334

(3006504) Eosinophils/Leukocytes in Blood

2212

15529

2.03

94.43

8.8

6.6

2.90

2.80

1.12

2084

14609

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

20.37

94.22

1.1

1.0

0.31

0.04

u/ml

0.65

(3019069) Monocytes/Leukocytes in Blood

2216

15579

2.03

94.07

8.9

6.7

8.45

8.58

1.34

2093

14671

(3022096) Basophils/Leukocytes in Blood

2209

15520

2.03

93.85

8.9

6.7

0.66

0.69

1.51

2082

14585

(3013115) Eosinophils [#/volume] in Blood

2405

17503

2.04

91.46

9.0

6.8

0.21

0.19

e9/l

2.97

2145

15377

(3006315) Basophils [#/volume] in Blood

2346

16940

2.02

91.00

8.7

6.5

0.04

e9/l

0.03

2040

14636

(3001604) Monocytes [#/volume] in Blood

2341

16918

2.02

90.25

8.7

6.5

0.57

0.56

e9/l

1.17

2042

14620

(3018010) Neutrophils/Leukocytes in Blood

2225

15810

2.00

89.85

8.6

6.5

56.59

56.33

0.49

2123

15147

(3019198) Lymphocytes [#/volume] in Blood

2384

17364

2.02

89.57

8.7

6.6

1.97

e9/l

0.04

2123

15394

(3002030) Lymphocytes/Leukocytes in Blood

2253

16092

2.00

89.48

8.7

6.6

28.53

29.11

1.77

2147

15325

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

10.03

83.89

1.1

1.2

0.31

0.29

g/l

1.01

(3013650) Neutrophils [#/volume] in Blood by Automated count

2512

18909

1.99

82.43

11.9

9.6

4.24

4.00

e9/l

3.77

2187

16425

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

10.12

80.95

1.1

1.2

108.07

106.99

0.12

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

314

1053

3.16

72.54

2.0

1.9

1.25

1.18

g/l

3.52

305

999

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

303

1018

3.15

69.71

2.1

1.9

0.24

0.23

g/l

1.72

293

967

(3023368) Bacteria identified in Blood by Culture

1233

7672

1.90

68.63

5.3

4.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

837

4766

1.97

59.37

2.4

1.9

—

(3037522) Nuclear Ab [Titer] in Serum

861

4958

1.96

59.06

1.5

1.4

482.03

529.49

titre

0.33

197

1020

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1159

7372

1.83

58.23

2.6

1.9

0.97

1.12

mg/l

0.76

870

5616

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2119

16073

1.73

57.01

7.6

6.3

10.59

11.36

umol/l

1.92

2042

15286

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

2865

23799

1.86

55.19

5.7

4.2

11.49

10.69

mm/h

2.61

2725

22413

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2865

23824

1.85

54.67

10.5

7.7

79.14

77.84

u/l

0.75

2760

22662

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1801

13433

1.65

48.45

8.4

6.6

1.22

1.21

mmol/l

0.44

1709

12476

(3024561) Albumin [Mass/volume] in Serum or Plasma

1785

13455

1.62

44.74

5.7

5.0

36.45

36.34

g/l

0.38

1706

12662

(3032080) INR in Blood by Coagulation assay

1710

12763

1.62

44.57

14.3

12.1

1.19

inr

0.09

1436

10580

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

12.78

44.33

1.1

0.10

0.02

u/ml

1.17

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1953

15104

1.61

43.61

9.2

7.1

1.22

mmol/l

0.41

1761

13145

(3027231) Wheat IgE Ab [Units/volume] in Serum

7.49

43.25

1.1

7.87

10.92

u/ml

0.13

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

116

284

4.18

42.78

1.4

1.2

4.10

3.05

u/ml

0.29

146

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

427

2148

2.11

41.52

2.0

1.7

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

2262

18248

1.60

41.31

6.2

5.0

6.59

6.48

mmol/l

1.45

2156

17029

(3031040) Bacteria [#/volume] in Urine by Automated count

2576

21482

1.63

40.66

6.1

4.4

633.18

1853.13

e6/l

1.42

272

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

856

5451

1.74

40.36

4.5

3.6

162.81

424.45

ng/l

4.18

573

3754

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1463

10713

1.60

39.91

4.2

3.3

51.60

96.22

ng/l

0.42

874

6483

(3033658) Prothrombin time (PT) actual/Normal

1149

8001

1.63

38.20

5.1

4.2

92.81

92.87

0.03

1124

7821

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

602

3526

1.84

37.40

2.3

1.8

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3514

32338

2.34

36.96

22.9

13.8

20.63

22.05

mg/l

2.01

3076

26138

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

1478

11002

1.57

36.68

4.5

3.3

—

1.93

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1351

9871

1.58

36.27

3.2

2.6

64.82

58.54

u/l

0.43

1272

9193

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

978

6640

1.64

35.54

1.4

1.3

27.03

26.92

iu/ml

0.01

283

1964

(3002582) Erythrocytes [#/volume] in Urine

1360

10028

1.56

34.68

4.3

3.2

110.80

80.43

e6/l

0.14

1056

7542

(3012494) Peanut IgE Ab [Units/volume] in Serum

142

5.15

34.63

1.2

13.17

23.65

u/ml

0.20

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

908

6105

1.64

34.07

1.4

1.3

13.70

9.22

u/ml

0.94

339

2471

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1230

8899

1.57

33.93

2.5

2.2

150.75

198.28

u/l

2.02

1171

8462

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

111

5.66

33.14

1.4

1.2

8.64

18.08

u/ml

0.53

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1477

11191

1.53

32.75

3.6

3.3

28.17

31.48

u/l

4.67

1391

10622

(3030467) Casts [#/volume] in Urine by Automated count

1201

8703

1.56

32.61

4.2

3.1

0.29

0.36

e6/l

0.79

893

6288

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

245

1083

2.35

32.50

1.2

1.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

621

3819

1.75

32.36

1.9

1.7

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1094

7779

1.57

32.21

3.1

2.5

333.30

325.05

umol/l

1.96

983

6997

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

530

3119

1.81

32.07

3.1

2.5

34.59

53.62

u/l

0.65

446

2638

(3000850) Epithelial cells [#/volume] in Urine

984

6849

1.59

31.66

3.3

2.6

7.42

7.02

e6/l

0.32

911

6220

(40758558) Short blood count panel - Blood

1331

9933

1.53

31.30

8.2

6.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

809

5392

1.64

31.04

3.6

2.8

1.02

1.23

e6/l

0.59

417

2770

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

196

803

2.52

30.70

1.3

1.4

7.16

15.36

iu/ml

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

264

1234

2.23

30.67

1.2

1.5

26.70

8.18

iu/ml

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

755

4966

1.65

30.46

3.7

2.9

4.02

3.39

e6/l

0.52

357

2335

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

329

1688

2.04

30.01

2.0

1.7

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1049

7498

1.55

29.73

3.9

3.2

1080.76

1141.70

ng/l

0.23

884

6316

(3007164) IgA [Mass/volume] in Serum or Plasma

1094

7906

1.54

29.45

1.8

1.5

2.17

2.21

g/l

0.42

688

5000

(3018095) Leukocytes [#/volume] in Urine

1546

12017

1.49

29.32

5.3

3.8

62.93

89.94

e6/l

1.06

1110

8114

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

553

3381

1.75

29.19

2.3

1.8

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

3442

31841

1.97

29.03

23.3

15.5

139.49

139.63

mmol/l

3.25

3399

31184

(3042936) Bacteria identified in Isolate by Culture

672

4344

1.67

28.84

2.3

2.0

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1681

13334

1.47

28.51

2.3

2.0

96.88

97.49

pmol/l

0.20

911

7083

(3026008) Bacteria identified in Urine by Culture

1288

9692

1.50

28.43

3.7

2.9

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

3443

31916

1.94

27.91

23.7

15.6

3.93

3.94

mmol/l

2.38

3395

31189

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

7.14

27.54

1.1

1.53

3.58

u/ml

0.53

(3005719) IgG [Mass/volume] in Serum or Plasma

438

2588

1.78

25.84

3.7

3.0

10.25

10.50

g/l

0.67

407

2410

(3018418) pH of Serum or Plasma

1192

8975

1.48

25.60

4.6

4.0

7.40

0.05

825

6342

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1151

8613

1.48

25.47

2.6

2.3

2.64

2.68

mg/l

0.26

984

7487

(3036481) Cortisol [Moles/volume] in Serum or Plasma

537

3374

1.69

25.42

2.6

2.2

350.07

379.27

nmol/l

2.63

513

3126

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

578

3705

1.66

25.35

3.1

2.9

5.63

7.09

umol/l

1.72

502

3221

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

223

1052

2.19

25.28

1.3

1.2

51.15

35.33

u/ml

0.30

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

399

2309

1.81

25.21

1.7

1.4

—

(3022948) Iron [Moles/volume] in Serum or Plasma

770

5304

1.57

25.07

2.7

2.5

13.14

13.76

umol/l

1.64

724

4962

(3004789) Transferrin [Mass/volume] in Serum or Plasma

719

4877

1.59

25.02

2.7

2.5

2.38

2.39

g/l

0.18

662

4527

(3003888) Timothy IgE Ab [Units/volume] in Serum

204

932

2.26

25.01

1.1

5.38

5.43

u/ml

0.01

139

528

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

7.18

25.00

1.1

1.0

0.32

0.07

u/ml

0.67

(3048689) Calprotectin [Mass/mass] in Stool

743

5082

1.58

24.93

2.5

2.6

105.99

113.25

ug/g

0.28

613

4063

(3023420) DNA double strand Ab [Units/volume] in Serum

279

1441

2.01

24.90

2.3

1.9

10.29

7.15

iu/ml

0.59

356

(3012095) Magnesium [Moles/volume] in Serum or Plasma

731

4987

1.58

24.79

4.7

3.9

0.81

0.82

mmol/l

0.51

690

4721

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

6.51

24.71

1.3

1.2

1.51

3.99

u/ml

0.68

(3028026) IgM [Mass/volume] in Serum or Plasma

361

2039

1.85

24.66

2.1

1.9

1.28

1.35

g/l

0.36

334

1899

(3014599) Egg white IgE Ab [Units/volume] in Serum

287

3.30

24.56

1.2

23.46

14.21

u/ml

0.21

(3026782) Osmolality of Urine

835

5886

1.54

24.44

3.4

2.8

525.95

526.00

mosm/kgh2o

0.00

766

5158

(40768797) Stomach Pathology biopsy report

649

4322

1.61

24.34

1.2

—

(3015736) pH of Urine

1746

14221

1.43

24.29

3.9

3.3

6.18

6.24

1.78

919

8052

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1858

15311

1.42

24.16

2.9

2.5

74.18

75.57

nmol/l

1.39

1718

14165

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

176

769

2.35

23.95

1.2

1.70

3.39

u/ml

0.54

(3044640) Blood type and Crossmatch panel - Blood

1357

10580

1.44

23.90

3.0

2.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1072

7995

1.48

23.80

2.9

2.3

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2947

26493

1.52

23.75

5.3

4.6

14.54

14.58

pmol/l

0.43

2761

24676

(3021589) Normoblasts [#/volume] in Blood

1819

14969

1.42

23.63

14.0

10.6

0.01

0.00

e9/l

0.60

1450

12171

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

3271

30139

1.66

23.44

19.0

12.9

88.11

87.20

ml/min/173m2

1.55

3025

27442

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

658

4437

1.59

23.32

2.8

2.6

21.92

23.20

1.68

617

4140

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

205

978

2.16

22.59

1.3

10.34

7.35

u/ml

0.22

156

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1194

9186

1.44

22.20

1.5

1.4

1.45

1.67

u/ml

0.32

288

2532

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

218

1075

2.09

22.05

2.3

1.9

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

158

684

2.37

21.97

6.6

6.3

1760.95

529.88

iu/ml

0.38

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

6.22

21.90

1.2

1.0

4.69

0.13

u/ml

0.84

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

397

2390

1.74

21.80

2.5

2.4

16.38

19.81

au/ml

0.57

297

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

316

1780

1.85

21.71

6.7

4.5

1.73

1.55

mmol/l

0.45

231

1318

(3020874) Milk IgE Ab [Units/volume] in Serum

294

3.11

21.67

1.3

1.2

14.94

3.34

u/ml

0.57

113

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

201

971

2.13

21.46

2.1

1.8

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

6.26

21.44

1.3

1.0

14.07

0.10

u/ml

0.53

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

202

979

2.12

21.38

1.3

3.15

6.68

u/ml

0.50

(3009261) Glucose [Presence] in Urine by Test strip

2098

17875

1.39

21.30

4.5

3.7

0.01

0.09

estimate

0.48

389

3561

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

371

2206

1.76

21.27

1.4

1.3

28.63

47.36

au/ml

0.96

134

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

460

2905

1.66

21.14

2.5

2.4

0.22

g/l

0.20

423

2729

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

349

2043

1.78

21.11

6.8

4.5

5.10

5.13

kpa

0.34

334

1978

(3010726) Horse dander IgE Ab [Units/volume] in Serum

188

892

2.17

21.01

1.2

1.1

2.70

1.70

u/ml

0.74

119

468

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

16.64

20.91

1.0

1.1

0.09

0.14

u/ml

—

(3000494) Fungus identified in Specimen by Culture

584

3929

1.58

20.69

1.7

1.4

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

261

3.19

20.64

1.1

4.75

2.02

u/ml

0.33

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1118

8589

1.43

20.62

1.9

1.7

—

(3035350) Ketones [Presence] in Urine by Test strip

2081

17762

1.38

20.57

4.5

3.7

3.38

4.28

estimate

0.09

412

3732

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

199

978

2.09

20.31

2.2

2.5

2.85

2.92

g/l

0.52

184

898

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

116

451

2.62

20.29

1.2

2.14

9.12

u/ml

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1093

8392

1.43

20.13

1.8

1.6

19.53

20.35

nmol/l

1.12

951

7236

(3014111) Lactate [Moles/volume] in Serum or Plasma

422

2641

1.67

20.03

8.8

8.4

1.29

1.31

mmol/l

0.18

415

2590

(3021601) Nitrite [Presence] in Urine by Test strip

2058

17580

1.38

19.97

4.5

3.7

0.00

estimate

0.29

412

3664

(40768443) Skin Pathology biopsy report

244

1299

1.94

19.92

1.3

1.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

206

1034

2.05

19.87

2.2

2.4

7.31

7.33

g/l

0.07

191

954

(3014051) Protein [Presence] in Urine by Test strip

1262

9967

1.40

19.68

3.4

2.8

0.18

0.04

0.33

180

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

205

1032

2.04

19.62

2.2

2.4

3.82

3.66

g/l

0.73

191

953

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

205

1034

2.04

19.52

2.2

2.4

4.31

4.24

g/l

0.71

191

953

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

186

3.54

19.36

2.3

2.8

704.49

960.92

u/ml

0.79

186

(3017143) Hepatitis C virus Ab [Presence] in Serum

691

4888

1.51

19.36

1.8

1.6

—

(3000991) Gas panel - Venous blood

424

2681

1.66

19.31

10.2

9.5

—

(3009343) pH of Capillary blood

335

1989

1.75

19.26

6.9

4.5

7.42

7.41

1.05

293

1661

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

185

903

2.10

19.23

2.4

2.5

0.38

0.99

g/l

2.20

161

793

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3565

33943

1.98

19.20

25.6

16.9

72.70

72.21

umol/l

0.44

3539

33551

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

207

1057

2.01

19.05

1.2

1.1

2.30

2.41

u/ml

0.06

130

583

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3270

30436

1.57

18.88

6.6

5.5

1.77

1.83

mu/l

2.58

3114

28684

(3008401) Mugwort IgE Ab [Units/volume] in Serum

183

902

2.08

18.55

1.1

2.41

1.06

u/ml

0.85

108

429

(40768804) Tissue Pathology biopsy report

1580

13037

1.37

18.53

2.2

2.0

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2589

23105

1.39

18.31

3.9

3.2

44.77

40.88

u/l

1.80

2481

22011

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

6.63

18.29

1.1

1.2

0.15

0.25

u/ml

0.21

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

163

779

2.14

17.91

1.8

2.4

0.00

0.01

g/l

0.97

144

714

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

173

846

2.10

17.91

1.6

1.3

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

632

4458

1.50

17.82

3.4

2.6

29.54

29.37

0.30

616

4335

(3017354) Segmented neutrophils/Leukocytes in Blood

261

2.99

17.46

4.3

3.1

54.99

56.18

0.18

233

(3016031) Almond IgE Ab [Units/volume] in Serum

6.55

17.46

1.2

1.1

1.43

0.97

u/ml

0.24

(3022313) Gas panel - Capillary blood

256

1446

1.83

17.39

7.5

4.7

—

(3017732) Neutrophils [#/volume] in Blood

599

4205

1.51

17.24

3.6

3.1

4.57

4.49

e9/l

0.10

510

3721

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

14.83

17.11

1.0

1.1

0.02

0.07

u/ml

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

248

1395

1.83

17.08

2.2

2.0

40.45

39.76

u/l

0.21

224

1278

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

123

534

2.35

17.05

3.6

4.0

297.80

1453.79

u/ml

—

(3019309) Folate [Moles/volume] in Red Blood Cells

634

4529

1.48

16.70

1.7

1095.52

1167.42

nmol/l

1.12

477

3446

(3003458) Phosphate [Moles/volume] in Serum or Plasma

574

4021

1.50

16.64

7.0

6.2

1.07

mmol/l

0.01

536

3749

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

243

1372

1.82

16.53

1.5

1.6

10.96

11.81

u/ml

0.12

358

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2057

17855

1.34

16.48

3.9

3.2

109.30

93.05

ug/l

1.37

1947

16898

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

5.57

16.48

1.3

1.0

0.49

0.73

u/ml

0.14

(3004616) Nuclear Ab [Presence] in Serum

390

2.55

16.41

1.4

1.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

218

1193

1.88

16.38

1.6

1.5

1.00

0.30

iu/ml

0.44

210

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

153

741

2.11

16.27

1.8

2.4

0.00

g/l

-0.00

133

662

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1802

15361

1.33

16.26

3.3

2.7

—

estimate

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

149

715

2.13

16.23

1.2

1.1

7.53

5.63

u/ml

0.42

330

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

146

698

2.14

16.06

1.8

2.4

0.00

g/l

-0.00

132

661

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

180

936

1.97

15.76

1.5

1.3

—

(3020630) Protein [Mass/volume] in Serum or Plasma

343

2170

1.64

15.50

3.3

2.8

66.85

66.58

g/l

0.27

316

2012

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2665

24156

1.36

15.30

4.2

3.4

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

154

766

2.05

15.27

1.2

1.1

5.02

3.82

u/ml

0.39

387

(3011841) English Walnut IgE Ab [Units/volume] in Serum

4.89

15.19

1.2

1.1

0.29

7.59

u/ml

1.30

(40760892) CBC W Ordered Manual Differential panel - Blood

1016

8017

1.37

15.07

5.1

4.5

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

251

2.86

14.99

1.3

1.2

86.86

42.58

u/ml

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

443

3003

1.54

14.90

6.7

4.6

5.81

5.82

kpa

0.11

435

2921

(3004809) Band form neutrophils/Leukocytes in Blood

417

2.41

14.73

4.3

3.4

0.85

1.46

1.57

381

(3022145) Colonoscopy Study observation

510

3574

1.49

14.64

1.4

—

(3002032) Base excess in Venous blood by calculation

432

2923

1.54

14.64

6.7

4.6

1.70

1.72

mmol/l

0.04

394

2516

(3015171) Extractable nuclear Ab [Units/volume] in Serum

239

1397

1.76

14.48

1.3

1.55

0.84

u/ml

0.27

101

(3012544) pH of Venous blood

442

3013

1.53

14.47

6.6

4.6

7.38

0.12

246

1744

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

126

593

2.16

14.45

1.5

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

126

593

2.16

14.45

1.5

1.3

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3531

33826

1.73

14.22

15.4

11.0

26.36

25.63

u/l

1.87

3483

32990

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

160

830

1.97

14.13

1.2

39.68

43.86

u/ml

0.10

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

168

889

1.93

14.00

1.9

2.4

10.26

10.33

g/l

0.07

151

803

(3024980) IgG subclass 4 [Mass/volume] in Serum

124

588

2.15

13.96

1.5

1.7

0.71

0.72

g/l

0.04

108

462

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3107

28998

1.41

13.94

6.5

5.5

38.57

38.16

mmol/mol

1.78

2937

27442

(3002179) Metamyelocytes/Leukocytes in Blood

396

2657

1.55

13.92

4.8

4.5

0.58

0.63

0.22

149

731

(3045414) Leukocytes [Presence] in Urine

442

3038

1.52

13.90

2.3

2.1

0.00

0.02

estimate

1.55

677

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

467

3250

1.50

13.84

6.0

4.4

233.61

243.63

u/l

0.95

450

3088

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

216

1243

1.78

13.81

1.4

1.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

162

851

1.94

13.80

3.3

2.8

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

251

1515

1.70

13.56

1.6

1.5

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1299

10764

1.32

13.52

3.5

3.3

2.35

2.36

mmol/l

0.51

1204

9910

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

154

803

1.96

13.41

2.0

1.5

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

213

1234

1.77

13.31

8.3

4.9

24.65

24.63

mmol/l

0.02

204

1166

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

267

1648

1.67

13.27

9.1

10.6

24.13

24.28

mmol/l

0.30

262

1618

(3019977) pH of Arterial blood

448

3118

1.50

13.24

8.0

8.4

7.42

0.97

207

1679

(3045424) Erythrocytes [Presence] in Urine

251

1529

1.69

13.11

2.3

2.1

0.01

0.49

estimate

0.51

528

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

447

3125

1.49

12.92

7.8

8.3

5.03

5.11

kpa

1.04

428

3002

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

107

494

2.20

12.91

1.2

688.00

320.69

titre

—

(3027801) Oxygen [Partial pressure] in Arterial blood

447

3126

1.49

12.89

7.8

8.3

12.57

12.90

kpa

0.60

428

3004

(3013139) Helicobacter pylori Ag [Presence] in Stool

351

2334

1.56

12.82

1.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1114

9090

1.32

12.79

2.3

2.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

461

3251

1.48

12.75

1.6

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

158

846

1.91

12.74

2.1

1.5

—

(3017181) Myelocytes/Leukocytes in Blood

405

2786

1.51

12.65

5.2

4.7

0.87

0.90

0.06

148

774

(3002173) Hemoglobin [Mass/volume] in Arterial blood

380

2581

1.53

12.60

8.4

9.2

121.47

121.37

g/l

0.03

367

2522

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

259

2.66

12.52

2.9

3.1

209.02

214.34

e6/l

0.10

211

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

131

664

2.01

12.39

1.1

0.49

0.38

u/ml

0.15

225

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

427

2983

1.49

12.36

1.3

1.2

105.08

154.25

u/ml

2.77

151

1134

(3021440) Promyelocytes/Leukocytes in Blood

390

2678

1.51

12.28

5.3

4.8

0.10

0.11

0.13

132

666

(3003396) Base excess in Arterial blood by calculation

440

3098

1.48

12.25

7.8

8.3

0.49

0.89

mmol/l

1.25

371

2529

(3019225) pH of Specimen

386

2648

1.51

12.21

5.6

3.9

7.38

7.35

5.57

309

1899

(36660697) Celiac disease serology panel - Serum

452

3208

1.46

12.07

1.3

1.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

756

5878

1.36

11.92

2.9

2.8

2.43

2.44

mmol/l

0.90

679

5287

(3003327) Ova and parasites identified in Stool by Light microscopy

233

1429

1.67

11.87

1.7

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

250

2.63

11.77

2.9

3.1

605.83

566.14

e6/l

0.23

195

(3023419) Bacteria identified in Sputum by Culture

354

2.35

11.63

3.7

2.8

—

(3016502) Oxygen saturation in Arterial blood

396

2759

1.49

11.60

8.1

8.8

95.38

95.81

0.54

381

2670

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

157

867

1.85

11.53

2.4

2.2

12.18

11.60

mg/l

0.35

146

817

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

184

1070

1.76

11.39

4.2

3.1

188.63

181.22

0.53

176

1029

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

364

2.31

11.36

1.8

1.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

185

1079

1.75

11.33

1.2

1.1

3.72

4.76

0.77

149

(3005988) Vibrio sp identified in Specimen by Organism specific culture

365

2.30

11.29

1.8

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

285

2.48

11.29

5.6

4.0

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

344

2343

1.52

11.24

3.8

3.9

86.38

78.48

ng/l

0.62

310

2053

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

111

550

2.05

11.21

1.3

4.64

4.28

u/ml

0.12

248

(3024139) IgG subclass 3 [Mass/volume] in Serum

354

2.32

11.18

1.3

1.4

0.34

0.39

g/l

0.87

255

(3028192) IgG subclass 2 [Mass/volume] in Serum

354

2.32

11.18

1.3

1.4

2.99

2.93

g/l

0.13

257

(3027135) IgG subclass 1 [Mass/volume] in Serum

355

2.31

11.11

1.3

1.4

6.55

6.56

g/l

0.01

258

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

465

2.14

11.09

1.2

—

(3020779) Urea [Moles/volume] in Serum or Plasma

371

2574

1.49

11.09

9.7

8.0

8.32

8.54

mmol/l

0.29

355

2482

(3025159) Blasts/Leukocytes in Blood

390

2734

1.48

11.07

5.7

4.9

0.16

0.22

0.18

129

634

(4062490) Immunoglobulin typing, IgG

350

2.31

11.02

1.4

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

5.74

11.00

1.2

1.0

37.20

12.47

u/ml

0.54

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

383

2.25

10.93

1.8

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

379

2.24

10.78

1.8

1.4

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

171

990

1.76

10.76

2.5

2.3

199.77

384.31

ug/l

1.95

157

927

(3036489) Thrombin time

216

1334

1.66

10.73

3.6

2.8

20.32

21.04

1.85

194

1165

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

253

1626

1.60

10.71

2.1

1.9

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

242

1541

1.61

10.64

9.7

10.9

16.08

16.04

0.08

232

1481

(3020961) Endomysium IgA Ab [Titer] in Serum

297

1983

1.54

10.64

1.2

1.1

289.00

113.85

titre

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

307

2065

1.53

10.63

2.2

6.89

6.95

ug/l

0.02

258

1839

(3025468) Yersinia sp identified in Specimen by Organism specific culture

362

2.26

10.63

1.8

1.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

223

1392

1.64

10.63

1.3

1.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

162

927

1.78

10.61

1.3

1.4

312.87

291.76

ug/g

0.60

502

(3000475) Leukocytes [#/volume] in Synovial fluid

133

716

1.89

10.60

1.9

1.7

21533.41

12121.94

e6/l

0.62

494

(3024891) Influenza virus A+B Ag [Presence] in Specimen

179

1055

1.73

10.58

1.3

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1519

13138

1.26

10.55

2.0

1.9

1.44

1.35

mmol/l

2.92

1313

11383

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

377

2.23

10.49

1.8

1.4

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

309

2.36

10.39

1.1

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

116

3.30

10.38

1.2

1.1

3.60

4.40

iu/ml

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

137

3.09

10.31

1.1

8.36

9.29

u/ml

0.07

(3023511) Choriogonadotropin [Units/volume] in Urine

196

1193

1.68

10.31

1.5

1.3

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

172

1012

1.73

10.24

2.0

0.69

1.77

ug/l

2.50

147

901

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

300

2.36

10.14

1.1

1.2

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

149

2.98

10.14

1.1

1.0

14.78

13.63

u/ml

0.09

106

(3013005) Retinol [Moles/volume] in Serum or Plasma

183

2.76

10.01

2.0

2.2

1.98

1.91

umol/l

0.21

169

(3027945) Reticulocytes/Erythrocytes in Blood

445

3259

1.41

9.97

3.1

3.0

1.77

1.75

0.15

397

2940

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

290

2.37

9.96

1.1

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

303

2.34

9.92

1.1

1.2

—

(3025941) Bacteria identified in Stool by Culture

292

1974

1.52

9.88

1.3

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

147

836

1.79

9.85

3.0

3.1

2.41

2.07

index

0.15

446

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

299

2.33

9.76

1.1

1.2

—

(3002256) Pathology report gross observation

548

4175

1.37

9.68

1.3

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

5.30

9.63

1.3

1.56

1.41

iu/ml

—

(3009508) Creatinine [Moles/volume] in Urine

1202

10199

1.26

9.58

3.7

3.5

7.76

7.61

mmol/l

0.44

1025

8819

(3011412) CD3 cells [#/volume] in Blood

335

2.23

9.46

2.7

2.9

1408.05

1308.26

e6/l

0.38

285

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

108

565

1.94

9.42

1.3

4.10

3.44

u/ml

0.13

199

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

349

2.20

9.39

2.0

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

104

538

1.96

9.37

2.1

1.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

916

7541

1.28

9.31

1.9

1.8

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

341

2412

1.46

9.22

3.5

4.59

4.54

pmol/l

0.29

305

2185

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

288

2.31

9.21

1.2

—

(4268621) Lupus anticoagulant assay

393

2.11

9.11

2.2

2.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

106

3.23

9.02

1.7

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

106

3.23

9.02

1.7

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

150

2.82

8.84

1.6

1.4

—

(3018333) Ribosomal P Ab [Presence] in Serum

281

2.30

8.82

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

798

6494

1.29

8.82

2.7

2.3

—

(44790049) Parainfluenza type 3 nucleic acid detection

441

2.02

8.70

2.0

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

441

2.02

8.70

2.0

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

441

2.02

8.70

2.0

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

441

2.02

8.70

2.0

1.5

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

288

1994

1.48

8.70

1.1

0.92

2.55

u/ml

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

101

532

1.92

8.66

1.1

118.63

116.31

0.29

484

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

309

2.22

8.65

2.2

1.6

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

138

803

1.75

8.60

5.3

4.8

0.32

0.36

iu/ml

0.86

435

(3010838) Calcium [Moles/time] in 24 hour Urine

106

569

1.89

8.59

2.1

2.0

4.92

5.21

mmol/24h

0.47

510

(3024354) Oxygen [Partial pressure] in Venous blood

355

2564

1.42

8.58

6.6

4.2

4.75

4.67

kpa

0.33

347

2490

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

147

2.81

8.58

1.6

1.4

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

390

2.07

8.53

1.1

95.50

95.71

0.02

368

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

577

4524

1.33

8.35

1.8

1.42

1.41

0.07

499

4044

(3030981) Hyaline casts [#/volume] in Urine by Automated count

325

2325

1.44

8.28

2.8

2.4

0.48

0.40

e6/l

0.19

305

2211

(3049717) Cytology report of Urine Cyto stain

139

821

1.72

8.23

2.3

2.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

129

746

1.76

8.23

1.5

1.4

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

349

2.11

8.20

1.2

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

4.22

8.19

1.4

1.0

2.90

4.93

u/ml

0.52

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

108

593

1.85

8.18

1.9

1.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

126

730

1.75

7.99

1.8

1.4

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

130

760

1.74

7.99

1.1

4.45

16.52

au/ml

5.44

190

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

104

569

1.85

7.98

1.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

184

1179

1.59

7.95

4.0

3.7

97.15

94.05

1.24

178

1138

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

278

1947

1.46

7.93

4.1

3.1

138.28

177.58

ng/l

1.49

247

1755

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

6.09

7.83

1.7

2.50

1.13

mg/l

0.46

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

729

5946

1.28

7.81

2.6

2.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

316

2275

1.42

7.78

1.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

265

2.25

7.76

1.2

230.00

197.06

titre

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

173

2.56

7.74

1.5

47.00

19.17

u/ml

—

(3026389) Candida sp identified in Specimen by Organism specific culture

489

1.90

7.72

1.2

1.3

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

18.38

7.59

1.0

0.11

0.03

u/ml

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

255

2.25

7.57

1.9

1.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

255

2.25

7.57

1.9

1.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

255

2.25

7.57

1.9

1.4

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

146

2.69

7.56

2.2

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

146

2.69

7.56

2.2

1.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

146

2.69

7.56

2.2

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

146

2.69

7.56

2.2

1.5

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

135

2.76

7.53

1.1

1.0

0.69

1.22

u/ml

0.31

135

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

4.10

7.53

1.1

1.0

0.27

1.01

u/ml

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

3.17

7.52

1.8

1.6

—

(3028626) Oxygen [Partial pressure] in Capillary blood

154

963

1.62

7.38

8.9

5.2

8.89

8.86

kpa

0.07

149

946

(4195642) Thrombophilia screening test

533

1.84

7.37

1.2

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

5.96

7.36

1.7

1.17

2.23

mg/l

0.50

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

5.96

7.36

1.7

3.84

4.81

mg/l

0.16

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

5.96

7.36

1.7

0.26

0.98

mg/l

2.19

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

5.96

7.36

1.7

2.80

3.48

mg/l

0.17

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

5.96

7.36

1.7

0.73

1.42

mg/l

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

5.96

7.36

1.7

2.34

3.14

mg/l

0.15

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

5.96

7.36

1.7

1.20

3.24

mg/l

0.87

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

5.96

7.36

1.7

1.93

0.95

mg/l

1.15

(3010813) Leukocytes [#/volume] in Blood

3635

35571

1.67

7.31

32.4

21.2

7.01

6.72

e9/l

6.39

3583

34837

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

135

819

1.67

7.28

1.8

1.6

3.55

3.66

mmol/l

0.84

119

773

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

9.36

7.27

1.0

1.1

1.56

0.06

u/ml

0.45

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3130

29898

1.28

7.23

5.3

4.5

5.87

5.77

mmol/l

3.21

2927

27840

(3020682) Albumin/Creatinine [Ratio] in Urine

1040

8908

1.23

7.20

4.5

4.2

8.61

8.77

mg/mmol

0.04

620

5560

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

133

2.72

7.17

2.3

2.2

7.81

9.91

mg/l

1.18

118

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

533

4221

1.31

7.13

2.3

2.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

170

1099

1.57

7.10

5.3

3.5

3.67

3.53

g/l

0.63

162

1050

(3023520) Reticulocytes [#/volume] in Blood

328

2417

1.39

7.07

3.1

2.8

73.55

70.29

e9/l

0.79

235

1728

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

165

1061

1.58

7.06

1.3

—

(3007461) Platelets [#/volume] in Blood

3632

35552

1.65

7.05

32.4

21.2

262.27

259.35

e9/l

1.91

3594

34912

(3007566) Smooth muscle Ab [Titer] in Serum

152

960

1.61

7.01

1.2

1.3

73.85

85.84

titre

0.33

(3037121) Protein [Mass/volume] in Urine

165

1064

1.58

6.97

3.9

3.7

1405.24

387.75

mg/l

0.60

499

(3035941) MCH [Entitic mass]

3632

35561

1.64

6.93

32.3

21.1

30.09

30.13

0.84

3617

35250

(3024731) MCV [Entitic mean volume] in Red Blood Cells

3632

35561

1.64

6.93

32.3

21.1

90.39

90.40

0.04

3617

35251

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

3632

35564

1.64

6.89

33.1

21.6

40.18

40.79

1.69

3616

35237

(3026361) Erythrocytes [#/volume] in Blood

3632

35566

1.64

6.86

32.4

21.1

4.50

e12/l

0.55

3579

34851

(3000963) Hemoglobin [Mass/volume] in Blood

3632

35576

1.63

6.72

32.6

21.3

134.32

134.88

g/l

1.71

3617

35264

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

103

594

1.75

6.70

1.8

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

660

5411

1.27

6.70

1.7

1.6

—

(3011985) Renin [Units/volume] in Plasma

471

1.85

6.64

1.7

1.6

68.28

60.82

mu/l

0.10

428

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

5.88

6.60

1.3

1.4

0.30

0.24

iu/ml

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

175

2.42

6.60

1.3

1.2

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

318

2.03

6.57

1.5

1.6

56.03

56.15

0.01

202

(3012516) Albumin [Mass/volume] in Urine

1018

8774

1.22

6.52

3.9

3.5

44.82

49.30

mg/l

0.34

623

5551

(3002523) Influenza virus A Ag [Presence] in Specimen

129

804

1.63

6.31

1.1

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

11.03

6.29

1.1

0.81

0.03

u/ml

—

(3003740) Influenza virus B Ag [Presence] in Specimen

128

802

1.62

6.14

1.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

182

1235

1.50

6.14

1.8

1.9

1.55

1.49

g/l

0.40

162

1090

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

208

2.23

6.03

1.8

2.0

8.57

1.81

u/ml

0.47

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

436

3440

1.30

5.97

4.9

4.4

30.63

32.35

2.91

319

2390

(1616796) Gas panel - Central venous blood

105

634

1.68

5.84

3.8

3.5

—

(3035320) C reactive protein [Mass/volume] in Body fluid

271

2.04

5.82

3.7

2.3

25.02

26.41

mg/l

0.11

183

(44813793) Dust mix specific IgE antibody measurement

278

2.03

5.81

1.1

1.0

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

101

607

1.68

5.72

1.7

1.4

—

(3044290) Cell count panel - Cerebral spinal fluid

120

754

1.61

5.72

1.9

1.8

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.98

5.68

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

217

1552

1.42

5.60

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

454

1.78

5.56

1.7

1.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

397

1.83

5.51

1.2

1.3

0.18

0.22

nmol/l

0.45

309

(37208534) Antinuclear antibody arbitrary concentration in serum

111

2.63

5.47

1.0

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

157

1060

1.50

5.46

1.1

2.59

5.46

eliau/ml

1.23

159

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

441

3530

1.28

5.41

2.1

2.0

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

203

1448

1.42

5.33

2.3

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

409

1.80

5.31

2.0

1.6

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

605

1.65

5.30

1.1

1.2

—

(3027315) Oxygen [Partial pressure] in Blood

590

1.66

5.28

3.8

8.85

8.86

kpa

0.01

583

(3017446) Testosterone [Moles/volume] in Serum or Plasma

292

2217

1.34

5.26

2.4

2.2

10.52

12.13

nmol/l

2.61

258

2027

(3000060) B lymphocytes [#/volume] in Blood

150

2.35

5.23

3.2

3.4

0.28

0.27

e9/l

0.05

(4024509) Urine culture

207

1487

1.41

5.23

1.8

1.9

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

577

1.66

5.21

1.2

1.1

3.04

2.55

0.09

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

2934

28077

1.21

5.21

25.9

17.0

13.53

13.45

2.79

2916

27698

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

117

749

1.58

5.19

1.4

143.51

142.79

au/ml

0.02

220

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

399

1.79

5.13

1.8

1.5

—

(3023183) Ammonium ion [Moles/volume] in Plasma

102

637

1.62

5.03

2.3

2.8

32.04

33.27

umol/l

0.24

585

(3013290) Carbon dioxide [Partial pressure] in Blood

591

1.64

5.01

3.8

4.80

5.01

kpa

2.31

584

(3012501) Base excess in Blood by calculation

591

1.64

5.01

3.7

3.8

2.49

2.46

mmol/l

0.03

374

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

192

2.15

5.00

1.1

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

217

1586

1.39

4.98

1.5

1.7

0.26

0.30

mg/l

0.51

725

(3014765) Yersinia sp identified in Stool by Organism specific culture

141

951

1.50

4.96

1.3

1.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

167

2.23

4.93

2.2

1.4

13.81

12.97

u/l

0.26

159

(3000093) Morphology [Interpretation] in Blood Narrative

268

1.95

4.91

1.1

—

(3022621) pH of Urine by Test strip

343

2692

1.30

4.90

2.5

6.12

6.14

0.15

211

1729

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

122

801

1.54

4.87

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

314

2439

1.31

4.84

2.5

2.3

4608.89

6441.57

u/l

0.69

108

971

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

312

1.87

4.84

1.7

1.3

5.69

5.41

umol/l

0.20

283

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1474

13398

1.16

4.83

4.2

3.5

1.46

0.07

estimate

0.47

347

3010

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

109

699

1.58

4.83

4.3

3.4

6.38

3.50

ratio

0.34

403

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

292

1.90

4.78

1.1

1.2

52.68

75.21

u/l

1.25

264

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

139

943

1.49

4.77

1.3

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

3.17

4.76

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

237

2.00

4.74

1.2

1.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

120

791

1.53

4.72

4.9

3.6

38.33

45.69

mg/l

0.53

107

687

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

136

923

1.49

4.67

1.8

1.6

487.80

509.32

mg/l

0.17

123

877

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

253

1.95

4.63

4.0

3.6

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1107

9865

1.17

4.62

3.6

3.1

1.58

0.14

estimate

0.75

333

2922

(42529406) Shigella sp [Presence] in Stool by Culture

140

958

1.48

4.62

1.3

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

3.22

4.61

1.9

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

2959

28430

1.19

4.58

26.3

17.4

332.18

332.54

g/l

1.08

2946

28263

(3034860) Kappa light chains.free [Mass/volume] in Serum

119

790

1.52

4.54

4.9

3.6

41.33

57.30

mg/l

0.96

107

684

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

276

1.90

4.54

2.9

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

163

1155

1.43

4.49

5.7

4.9

1.56

1.60

0.19

150

1087

(3034274) Bile acid [Moles/volume] in Serum --fasting

115

760

1.53

4.49

2.5

4.74

6.29

umol/l

1.08

561

(3028679) Herpes simplex virus Ab [Presence] in Serum

256

1.93

4.48

1.3

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

121

809

1.51

4.47

1.6

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3054

29442

1.20

4.47

4.3

3.9

1.34

1.25

mmol/l

9.10

2888

27582

(40757373) Influenza virus identified in Isolate

3.27

4.46

1.7

1.5

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

155

2.20

4.46

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

130

2.32

4.42

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

100

2.51

4.37

3.2

1.8

40.18

40.40

g/l

0.07

100

(3028433) Virus identified in Specimen by Culture

101

2.49

4.29

1.4

1.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3206

31077

1.22

4.28

5.0

4.5

1.43

1.49

mmol/l

10.86

3037

29323

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

311

1.81

4.27

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

438

1.68

4.26

1.4

276.26

337.63

pmol/l

1.33

381

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

102

665

1.55

4.25

2.2

2.5

1.04

0.85

nmol/l

1.21

578

(3036603) Volume of Urine

233

1.94

4.24

1.4

1.5

2256.78

1992.76

0.77

228

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

114

2.38

4.23

2.7

1.5

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

717

6203

1.19

4.21

1.7

20099282.77

34298109.21

pmol/l

0.29

607

5254

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.42

4.18

2.0

1.6

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3219

31235

1.21

4.14

5.1

4.6

4.67

4.70

mmol/l

1.03

3063

29619

(3047007) Chlamydophila sp Ab [Presence] in Serum

606

1.57

4.13

1.3

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3247

31537

1.22

4.11

5.7

5.1

2.78

2.77

mmol/l

0.27

3086

29779

(21494434) Karyotype in Bone marrow

237

1.91

4.05

1.3

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.94

4.00

1.2

1.4

1.16

1.19

mmol/l

1.01

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

120

822

1.48

3.99

1.9

1.7

386.02

5873.74

e6/l

0.61

627

(3036670) Protein [Mass/volume] in Synovial fluid

2.68

3.98

1.5

1.1

43.54

39.28

g/l

0.72

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

124

2.27

3.96

1.1

89.60

90.57

—

(3042631) Mycobacterium sp identified in Specimen

312

1.77

3.94

3.3

2.8

—

(3008898) HLA-B27 [Presence]

201

1513

1.35

3.90

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

356

2893

1.25

3.88

3.5

3.1

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

192

1.99

3.87

2.5

2.8

40.06

43.28

0.44

102

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

126

2.23

3.82

1.6

2.1

831.40

28617.00

u/ml

—

(3045142) Bone marrow Pathology biopsy report

331

1.73

3.78

1.5

1.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

294

1.78

3.78

1.3

1.1

—

1.48

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

114

2.29

3.77

2.8

1.5

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

114

2.29

3.77

2.8

1.5

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

117

810

1.46

3.71

1.9

1.7

40.69

38.06

e6/l

0.03

581

(4035726) Immunohistochemistry procedure

313

2520

1.26

3.70

1.4

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

312

1.74

3.66

2.0

10.43

24.01

mg/l

3.82

119

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

103

699

1.49

3.62

1.5

1.4

22.64

24.44

u/l

0.19

594

(1761868) Lipid panel - Serum or Plasma

1252

13658

0.88

3.61

2.9

2.8

—

(3035933) Granulocytes/Leukocytes in Blood

109

749

1.47

3.60

2.9

3.2

59.12

57.25

0.90

109

749

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

123

2.20

3.60

1.1

1.4

79.00

90.26

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

489

4144

1.21

3.58

1.8

—

(3011288) Drugs identified in Urine by Screen method Nominal

205

1575

1.32

3.49

1.9

3.0

—

(3019150) Specific gravity of Urine by Refractometry

883

7896

1.15

3.38

4.2

3.8

1.02

1.41

kg/l

0.80

571

5185

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

2.58

3.38

1.3

1.2

476.08

295.73

pmol/l

0.69

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

291

1.73

3.33

1.7

1.3

2.03

1.47

nmol/l

2.05

261

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

182

1.93

3.33

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

247

1.79

3.31

1.6

1.4

153167.80

109545.46

e6/l

0.11

164

(3027273) Bicarbonate [Moles/volume] in Venous blood

158

1178

1.36

3.31

3.5

3.3

25.05

25.25

mmol/l

0.37

153

1130

(3033099) Centromere Ab [Titer] in Serum

2.62

3.30

1.1

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

354

1.65

3.26

1.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.78

3.25

1.7

1.5

34.00

76.40

ng/l

—

(1002224) Polysomnography panel

221

1734

1.29

3.25

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

164

1.96

3.18

5.6

2.2

234.80

150.92

umol/l

0.39

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

327

2697

1.23

3.16

4.0

4.3

13.61

29.67

ug/l

0.63

259

2114

(3020123) Porphyrins [Interpretation] in Serum or Plasma

4.01

3.08

1.3

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

254

1.74

3.04

4.0

2.7

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

255

1.73

3.01

1.4

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

104

736

1.42

3.00

1.4

1.5

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

294

2416

1.24

2.95

3.0

2.6

74.64

71.76

ml/min/173m2

0.60

131

1003

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

155

1.94

2.94

1.1

228.08

193.85

iu/ml

0.23

155

(40768795) Lymph node Pathology biopsy report

295

1.67

2.93

1.2

—

(3029937) Albumin [Presence] in Urine by Test strip

1046

9546

1.13

2.92

4.7

3.8

0.00

estimate

2.17

387

3472

(3051611) Lipemic interference index of Serum or Plasma

288

1.68

2.91

3.3

19.85

14.18

index

1.06

176

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

258

1.71

2.90

1.4

1.2

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

2.38

2.89

1.8

3.0

1.68

1.88

mmol/l

0.13

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

266

1.70

2.88

1.2

1.3

1.86

1.95

mmol/l

0.41

244

(3046861) Legionella sp Ag [Presence] in Urine

6.67

2.86

1.0

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

172

1332

1.31

2.83

4.8

3.7

49.90

48.87

0.21

172

1308

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.34

2.81

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

137

1.98

2.79

2.4

2.3

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

187

1.83

2.78

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

3.58

2.78

1.3

1.0

—

(3020876) Protein [Mass/time] in 24 hour Urine

323

1.62

2.77

2.9

2.4

1.42

1.24

g/24h

0.25

196

(3021387) Prolactin [Units/volume] in Serum or Plasma

232

1871

1.26

2.77

1.7

310.47

297.55

mu/l

0.27

206

1698

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

386

1.56

2.77

1.1

1.3

—

nmol/l

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.27

2.77

1.2

—

(3010421) pH of Blood

127

945

1.36

2.75

3.4

7.42

7.41

3.02

127

938

(3019832) Treponema pallidum Ab [Presence] in Serum

652

5786

1.15

2.75

1.9

1.8

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

427

1.53

2.74

2.4

3.1

72.31

34.54

u/ml

0.26

421

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

104

2.12

2.74

4.5

4.3

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

294

1.64

2.71

1.3

75.00

77.08

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

461

1.51

2.70

1.1

1.55

1.49

g/l

0.60

419

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

288

1.64

2.66

1.1

1.0

280.93

293.89

mg/l

0.60

262

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

343

1.58

2.65

1.3

1.4

—

titre

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

304

1.62

2.64

1.1

1.2

108.84

111.32

pmol/l

0.13

304

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

464

1.50

2.63

1.3

1.2

44.59

35.72

u/l

0.11

396

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

613

1.43

2.61

1.1

2.24

3.09

eliau/ml

0.47

301

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

539

1.46

2.60

1.7

1.5

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

177

1.81

2.59

1.5

1.18

1.32

nmol/l

0.29

132

(3014148) Varicella zoster virus Ab [Titer] in Serum

606

1.43

2.59

1.3

1.2

—

(3023410) Appearance of Cerebral spinal fluid

401

1.53

2.58

2.5

2.2

—

(4094501) Cardiovascular stress test using bicycle ergometer

109

801

1.37

2.58

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

322

1.59

2.57

1.3

1.2

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

4.01

2.56

2.9

1.4

52.75

45.75

umol/l

—

(3044242) Glucose [Moles/volume] in Arterial blood

156

1.87

2.56

2.3

2.2

7.42

8.51

mmol/l

0.79

156

(3047181) Lactate [Moles/volume] in Blood

109

802

1.37

2.56

5.8

5.9

1.37

1.27

mmol/l

0.58

699

(3044009) aPTT.lupus sensitive (LA screen)

3.23

2.51

1.0

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.27

2.50

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.27

2.50

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.27

2.50

1.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

115

2.01

2.50

1.1

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

200

1608

1.26

2.48

6.3

6.8

24.34

24.44

mmol/l

0.15

186

1533

(3045716) Anion gap in Serum or Plasma by calculation

286

1.62

2.48

5.0

2.5

11.02

10.45

mmol/l

0.54

281

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

2.39

2.46

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

139

1069

1.31

2.45

7.8

6.4

1.46

1.35

mg/l

0.86

133

1003

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

140

1078

1.31

2.44

2.1

3.14

8.72

iu/l

0.57

461

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

166

1.81

2.44

1.3

1.7

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

137

1052

1.31

2.44

6.1

5.2

0.84

0.88

0.61

126

986

(3019174) dRVVT (LA screen)

3.13

2.43

1.0

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

432

1.49

2.42

2.2

1.7

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.29

2.41

1.4

1.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

172

1364

1.27

2.40

1.6

1.5

10.59

9.91

u/l

0.26

141

1068

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

483

1.46

2.38

1.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

329

1.56

2.37

1.2

1.1

4.06

9.23

iu/ml

2.27

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

617

1.40

2.37

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.04

2.35

1.0

1.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

629

1.39

2.30

1.7

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

308

1.57

2.30

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

113

854

1.33

2.27

1.3

233.49

246.13

u/ml

0.18

515

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

333

1.54

2.27

1.2

1.5

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

127

1.90

2.25

1.0

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

294

1.57

2.24

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

135

1.86

2.22

1.2

1.1

54.56

269.06

ng/l

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.86

2.20

1.0

1.1

92.80

87.77

titre

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

626

1.38

2.20

1.3

—

(4015189) Microbial culture of sputum

2.50

2.18

3.2

2.7

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

3.69

2.15

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

3.69

2.15

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

362

1.50

2.14

1.1

1.2

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

227

1.64

2.14

1.8

3.74

3.73

mg/l

0.00

220

(3023323) Follitropin [Units/volume] in Serum or Plasma

307

2624

1.19

2.12

1.4

26.45

24.06

iu/l

0.60

255

2201

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.05

2.11

1.9

1.3

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

589

1.38

2.10

1.9

1.6

386.98

353.88

mu/l

0.30

477

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

102

1.97

2.10

1.2

1.4

108.99

127.20

nmol/l

0.27

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

389

1.47

2.08

1.1

—

4.24

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

324

1.52

2.08

1.1

8.23

16.23

u/ml

2.49

140

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.08

2.06

8.4

3.7

10.28

10.72

kpa

0.39

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.08

2.06

8.4

3.7

5.03

4.70

kpa

0.71

(3027456) Digoxin [Moles/volume] in Serum or Plasma

440

1.44

2.05

3.4

0.88

0.81

nmol/l

0.25

361

(3003694) ABO and Rh group [Type] in Blood

1143

10671

1.10

2.02

1.6

—

(3039000) Anion gap in Blood by calculation

526

1.40

2.01

7.1

7.3

11.58

11.35

mmol/l

0.31

471

(3003329) Lymphocytes/Leukocytes in Synovial fluid

239

1.60

2.01

1.6

1.5

24.44

36.47

1.41

149

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.05

2.01

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

620

1.36

2.00

1.1

—

(3034426) Prothrombin time (PT)

111

1.90

2.00

1.0

1.3

29.76

28.68

0.30

111

(3006922) Hepatitis E virus Ab [Presence] in Serum

271

1.56

2.00

1.0

1.1

—

(3018572) Chloride [Moles/volume] in Blood

527

1.39

1.99

7.2

7.3

105.26

105.24

mmol/l

0.01

472

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

3.75

1.93

1.2

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

3.75

1.93

15.0

5.8

—

(3000330) Specific gravity of Urine by Test strip

180

1479

1.23

1.91

3.6

3.2

1.02

ratio

0.07

152

1316

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.25

1.90

1.1

0.66

0.70

umol/24h

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

219

1.60

1.90

1.1

1.44

1.12

u/l

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.65

1.86

1.0

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

123

971

1.28

1.85

3.4

3.7

192.17

1676.11

u/ml

0.82

839

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

229

1.58

1.84

1.8

1.5

—

(3020393) Adenovirus Ag [Presence] in Stool

2.13

1.81

2.6

1.9

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.13

1.81

1.0

1.1

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

2.58

1.80

1.7

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

344

1.46

1.80

1.1

—

(3008037) Lactate [Moles/volume] in Venous blood

608

1.34

1.77

4.3

2.8

1.45

1.49

mmol/l

0.24

587

(3042733) HLA Ab [Presence] in Serum

109

1.84

1.77

4.2

4.6

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

289

1.49

1.74

1.1

—

(3001556) Androgen free Index in Serum or Plasma

2.23

1.73

1.0

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

241

1.54

1.73

2.6

2.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

3.85

1.71

1.0

1.1

—

(3024932) HLA-DR beta [Type]

103

1.85

1.71

1.2

1.1

—

(3044927) Protein electrophoresis panel - Urine

242

1.53

1.70

1.2

1.1

—

(3037756) Immunofixation for Serum or Plasma

502

1.36

1.67

3.0

1.6

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

134

1.72

1.66

1.0

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.58

1.66

1.8

4.0

—

(3006462) Nitrate [Presence] in Urine

142

1.69

1.64

3.1

2.9

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

608

1.32

1.63

1.1

174.16

951.32

iu/ml

0.45

149

(3024471) HLA-A [Type]

105

1.81

1.62

1.0

—

(4146454) Self-monitoring of blood glucose

270

1.49

1.61

2.6

2.7

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

105

832

1.27

1.58

1.7

1.5

0.54

0.41

nmol/l

0.26

659

(3006184) Hemoglobin [Mass/volume] in Capillary blood

683

1.30

1.56

2.5

2.2

129.96

130.22

g/l

0.03

548

(3025130) Human papilloma virus identified in Specimen

754

1.28

1.55

1.8

1.9

—

(3002619) Bacteria identified in Specimen by Culture

1.89

1.54

1.3

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

130

1.70

1.52

1.2

1.4

—

(4211845) Urine protein measurement

161

1.62

1.52

3.0

2.8

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

106

848

1.26

1.49

1.3

1.4

2.61

3.93

ug/l

2.62

777

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.90

1.49

1.0

1.1

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

259

1.47

1.48

1.4

1.5

11.90

11.18

umol/l

0.25

243

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.44

1.47

1.1

1.2

19.80

33.51

mg/l

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

318

1.42

1.46

1.5

2.2

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

2.37

1.45

4.2

3.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

310

1.42

1.45

1.6

1.7

—

(3032057) Clostridioides difficile [Presence] in Stool

2.12

1.44

2.1

2.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.13

1.44

1.0

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

111

1364

0.81

1.43

1.7

1.8

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

196

1676

1.18

1.43

1.4

1.3

195.63

226.42

miu/ml

0.66

844

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

172

1.57

1.42

1.7

1.5

4.67

5.43

u/l

0.12

144

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.25

1.40

1.7

1.8

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

126

1.67

1.40

1.1

1.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.08

1.38

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.94

1.36

1.0

1.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.76

1.34

2.1

2.7

0.59

0.62

mmol/l

0.78

(3006442) Creatine [Moles/volume] in Serum or Plasma

208

1.49

1.32

1.4

70.48

75.57

umol/l

0.90

208

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

176

1.54

1.31

1.0

1.1

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

2.29

1.26

1.0

175.00

168.34

g/l

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.29

1.26

1.3

1.1

—

(3008295) Osmolality of Serum or Plasma

363

1.35

1.24

1.6

1.4

282.71

279.63

mosm/kgh2o

0.46

273

(3017704) Immunofixation for Urine

131

1.61

1.23

1.8

1.7

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.97

1.22

2.4

1.9

—

(3045462) Protein/Creatinine [Ratio] in Urine

1.80

1.21

5.1

6.1

41.44

79.73

mg/mmol

0.59

(3004451) EKG impression Narrative

140

1.57

1.20

1.6

1.3

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.83

1.19

1.2

1.1

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

247

1.42

1.18

1.3

1.2

0.59

0.62

ratio

0.17

148

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

123

1463

0.84

1.18

1.7

1.6

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

232

2046

1.14

1.17

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

215

1.45

1.15

1.6

1.5

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.05

1.15

3.1

2.7

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

2.50

1.15

8.0

6.3

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

174

1.50

1.15

3.7

4.2

8.62

8.73

mg/l

0.03

145

(3002079) Sodium [Moles/time] in 24 hour Urine

158

1.52

1.14

1.1

1.4

159.96

159.59

mmol/24h

0.01

158

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

175

1.49

1.12

1.0

1.1

90.81

92.97

0.13

136

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

167

1.50

1.12

1.8

1.4

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.00

1.12

1.0

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

412

0.70

1.11

1.6

1.5

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

319

1.35

1.11

1.2

42.78

38.35

mg/l

0.16

264

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

512

1.27

1.10

2.5

34.57

34.40

iu/ml

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

176

1.48

1.10

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.38

1.09

3.0

2.1

—

(3052592) Norovirus Ag [Presence] in Stool

1.95

1.08

2.5

1.4

—

(3010937) Rubella virus Ab [Presence] in Serum

2.19

1.08

1.0

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

587

5473

1.09

1.07

5.4

5.0

2.20

2.34

ug/l

0.14

533

4937

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.12

1.05

10.3

5.5

—

(3047189) Immunofixation for 24 hour Urine

113

1.60

1.05

3.2

1.6

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

245

1.39

1.05

1.5

1.4

48876.78

87079.68

e6/l

0.42

137

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

231

2057

1.13

1.03

3.5

3.1

53.81

52.80

u/ml

0.02

221

1980

(3024869) Neuronal Ab [Presence] in Serum

1.96

1.03

1.0

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

187

1.45

1.03

1.8

1.4

—

(3014271) Vancomycin [Susceptibility]

106

1.61

1.02

2.9

2.6

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

307

1.34

1.01

1.1

184.78

245.93

mg/l

2.88

266

(3012898) Urea [Moles/volume] in Urine

2.00

1.00

2.1

1.4

261.44

192.23

mmol/l

—

(3043409) Potassium [Moles/volume] in Arterial blood

710

1.22

0.99

3.1

4.1

3.84

3.85

mmol/l

0.11

704

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

173

1.45

0.97

1.8

1.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

100

1185

0.84

0.97

1.5

1.6

61.31

60.29

ug/l

0.09

100

1185

(3024263) Appearance of Synovial fluid

132

1.52

0.97

1.7

2.0

—

(21494755) Public health laboratory ask at order entry panel

353

3847

0.91

0.96

1.4

1.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

224

1.39

0.96

1.2

1.1

1401.42

1448.61

miu/ml

0.09

224

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

243

1.36

0.92

1.2

1.5

—

(3022670) pH of Venous cord blood

2.14

0.91

1.2

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

168

1481

1.14

0.91

1.8

1.7

5.50

4.34

mg/l

0.46

133

1073

(3020191) Ethanol [Moles/volume] in Serum or Plasma

270

1.34

0.90

2.3

1.5

1.22

1.25

promille

0.05

219

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.91

0.88

8.7

5.3

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

103

878

1.18

0.87

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.86

0.87

1.0

1.2

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

213

1.36

0.84

1.1

1.2

10.28

8.73

mm/h

0.27

213

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.78

0.84

2.6

1.9

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

105

1.53

0.81

1.0

16.76

43.52

iu/ml

3.54

105

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.70

0.80

2.8

2.1

—

(3012441) Differential panel - Pleural fluid

241

1.33

0.80

1.5

1.4

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

164

1.40

0.79

1.3

1.2

16.09

12.88

u/l

0.40

150

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

114

1.49

0.79

1.0

1.3

—

(40768806) Pleura Pathology biopsy report

233

1.33

0.79

1.4

1.5

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.82

0.79

1.0

—

413.00

—

(3020650) Glucose [Presence] in Urine

123

0.57

0.77

1.0

1.7

0.00

0.02

estimate

—

123

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.77

0.76

1.0

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

354

3288

1.08

0.75

3.2

3.0

0.60

0.73

ug/l

2.82

207

1965

(3023383) Lactate [Moles/volume] in Pleural fluid

1.70

0.75

1.3

1.4

2.31

3.60

mmol/l

—

(3028717) Thiamine [Mass/volume] in Blood

1.67

0.74

1.1

1.3

76.44

65.96

ug/l

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

420

4479

0.93

0.73

1.8

3.42

3.43

ratio

0.04

312

3297

(40761995) Spermatozoa Progressive [#/volume] in Semen

108

0.55

0.72

5.2

3.1

50.83

44.48

—

108

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

108

0.55

0.72

10.3

6.1

9.50

8.10

—

108

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.61

0.72

1.1

1.4

—

146.50

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.67

0.72

1.1

1.0

14.19

5.36

u/ml

—

(3003434) Protein [Mass/volume] in Pleural fluid

308

1.27

0.72

1.4

34.71

33.19

g/l

0.30

282

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

326

1.26

0.71

1.8

2.3

31.63

32.13

0.37

326

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

221

1.31

0.69

1.4

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.51

0.69

1.1

—

(3017569) Oxygen content in Arterial blood

144

1.39

0.67

3.0

2.5

15.91

16.52

0.24

144

(3038515) Glucose [Moles/volume] in Venous blood

493

1.20

0.67

4.2

2.9

7.53

7.42

mmol/l

0.10

476

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.63

0.66

5.4

3.1

—

(3044007) Cell count panel - Peritoneal fluid

1.51

0.66

1.4

1.9

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

346

3234

1.08

0.65

7.1

6.0

—

(40765096) Chromosome analysis panel by Banding

1.48

0.64

1.3

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

138

1.38

0.62

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

459

4344

1.06

0.61

4.5

4.1

19.79

21.29

1.34

189

1910

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

165

1.34

0.60

2.4

1.8

—

(4034850) Laboratory test

106

940

1.13

0.59

9.2

9.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

131

1.38

0.59

1.3

1.5

53.33

295.98

nmol/24h

0.60

131

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.56

0.58

5.9

7.2

—

493.75

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

140

1.36

0.58

1.3

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

237

1.27

0.58

1.1

1.05

ratio

0.02

195

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

138

1526

0.90

0.57

1.4

1.5

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.72

0.57

1.0

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.72

0.57

1.0

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

237

2197

1.08

0.57

1.8

1.7

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

320

3409

0.93

0.57

1.6

3.44

mmol/l

0.02

207

2274

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.67

0.56

1.0

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.62

0.55

1.7

2.8

0.83

0.76

u/field

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

133

1.36

0.55

1.2

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

749

7215

1.05

0.54

1.6

1.5

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

116

1.38

0.54

1.3

1.2

—

(40758292) HTLV I+II Ab panel - Serum

1.49

0.53

1.3

—

(3041806) Other cells [#/volume] in Blood by Manual count

227

0.75

0.53

1.7

1.5

0.51

0.49

e9/l

0.15

227

(3023199) Leukocytes [#/volume] in Pleural fluid

286

1.23

0.52

1.5

1.4

3934.57

2510.48

e6/l

0.38

200

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

196

1.28

0.52

1.4

1.6

1.85

3.81

nmol/l

0.83

151

(3043410) Blood group antigens tested for on Red Blood Cells

0.61

0.51

1.8

1.3

—

(3034092) Cytoplasmic Ig cells/cells in Blood

1.50

0.51

11.3

8.8

0.18

0.22

—

(40768441) Liver Pathology biopsy report

242

1.24

0.51

1.2

1.5

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

753

1.13

0.51

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.41

0.50

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

118

1.36

0.50

4.4

3.3

1.00

1.22

0.22

118

(3005033) Fetal Nuchal fold Thickness US

143

1310

1.10

0.48

1.6

1.5

1.33

1.25

1.09

104

947

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

181

1.27

0.48

1.1

—

(3022229) Phosphate [Moles/volume] in Urine

1.49

0.47

2.3

3.2

14.84

20.55

mmol/l

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

111

1.35

0.46

1.6

3.2

80.50

134.20

ng/l

—

(44806420) Estimation of glomerular filtration rate

402

1.17

0.46

3.3

2.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.43

0.45

2.5

2.3

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

374

0.83

0.45

2.8

2.9

17.86

21.46

nmol/l

1.42

360

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

246

2312

1.07

0.45

4.6

3.5

1.23

mmol/l

0.51

212

1988

(3020491) Glucose [Moles/volume] in Blood

256

1.21

0.44

1.4

1.9

6.46

6.35

mmol/l

0.12

194

(3010370) Gastrin [Moles/volume] in Serum or Plasma

1.37

0.44

2.6

1.8

65.80

36.86

pmol/l

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.37

0.43

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

267

1.20

0.42

1.0

—

(3045788) Cell count panel - Pleural fluid

240

1.21

0.41

1.4

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.47

0.40

8.8

11.3

4.08

5.33

mmol/l

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.40

0.0

1.2

—

1.81

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

295

3103

0.95

0.39

1.6

1017.97

993.46

mu/l

0.17

250

2643

(3047352) Trisomy 18 risk [Likelihood] in Fetus

144

1335

1.08

0.39

1.6

1.5

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.39

0.38

1.0

1.1

2.04

1.66

umol/24h

—

(3051101) Glucose [Moles/volume] in Cord blood

1.39

0.38

4.0

6.1

7.06

8.28

mmol/l

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.34

0.38

1.1

1.2

—

(3006598) pH of Arterial cord blood

1.33

0.37

1.1

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

149

1597

0.93

0.36

1.6

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

725

1.11

0.36

2.1

1.8

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

356

1.15

0.36

2.3

5.0

80.85

68.12

u/ml

—

120

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.33

0.35

1.2

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

146

1363

1.07

0.35

1.7

1.6

—

(40768446) Kidney Pathology biopsy report

126

1.27

0.35

1.8

—

(3003181) Sodium [Moles/volume] in Urine

546

1.12

0.35

1.5

1.4

67.91

63.91

mmol/l

0.28

444

(3017509) Phencyclidine [Presence] in Urine

1.40

0.35

1.0

1.2

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

1.36

0.34

1.3

1.7

—

(4198724) Urine methamphetamine measurement

209

1.20

0.34

2.1

2.3

—

(40761536) Microorganisms panel - Urine sediment

286

2733

1.05

0.33

5.1

3.6

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.35

0.32

1.3

1.4

—

(40768793) Breast Pathology biopsy report

867

1.09

0.31

1.3

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

284

0.84

0.31

1.2

1.7

—

666.52

pmol/l

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.35

0.31

1.1

1.3

5.57

5.65

mmol/l

—

(4133840) Spirometry

1.31

0.30

1.1

1.2

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

1.27

0.30

2.3

1.8

7.71

604551.79

nmol/l

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

168

1590

1.06

0.29

1.5

—

(3006653) Thiamine [Moles/volume] in Blood

167

1.20

0.28

1.5

1.4

117.60

130.46

nmol/l

0.86

167

(3023487) Leukocytes [#/volume] in Peritoneal fluid

103

1.26

0.28

1.5

2.2

844.80

894.32

e6/l

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.25

0.27

1.3

1.2

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

168

1.19

0.27

1.8

1.9

135.95

99.82

ng/l

0.82

168

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.28

0.26

1.3

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

217

1.15

0.24

1.2

1.3

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

169

1612

1.05

0.24

1.6

1.5

1.17

ratio

0.00

962

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.32

0.23

1.0

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.32

0.23

1.2

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

169

1616

1.05

0.22

1.6

1.5

0.98

0.94

ratio

0.58

966

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

169

1616

1.05

0.22

1.6

1.5

1.21

ratio

0.00

973

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.19

0.21

1.4

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.21

0.0

1.6

—

1.45

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.21

0.0

5.1

—

432.42

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

103

0.78

0.21

1.1

1.2

—

9.33

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.16

0.21

1.6

1.2

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.0

—

3.69

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.20

0.0

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.20

0.0

12.4

—

(3000034) Microalbumin [Mass/volume] in Urine

229

0.87

0.20

2.6

3.1

159.23

35.30

mg/l

0.37

168

(3039443) Prostate specific Ag panel - Serum or Plasma

356

1.10

0.19

1.5

1.6

—

(21494814) CD8 cells/Lymphocytes in Specimen

118

1.19

0.19

1.4

2.1

37.07

29.46

0.89

118

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

185

0.86

0.18

1.3

1.4

134.79

159.60

pmol/l

0.43

185

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

100

1.20

0.18

2.3

2.2

12.41

16.32

umol/l

1.37

100

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

205

0.88

0.17

3.2

7.4

66.56

100.02

ug/l

0.14

128

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

234

1.11

0.16

1.6

1.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

267

0.90

0.16

1.5

1.6

—

(1617658) Protocol used for examination of sentinel lymph nodes

265

0.91

0.15

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

106

0.85

0.13

1.1

1.2

68.33

72.48

ug/l

—

106

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

148

0.88

0.12

1.0

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

206

2011

1.03

0.12

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

163

1.10

0.10

2.9

1.9

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

163

1.10

0.10

2.9

1.9

—

(3029396) Erythrocyte agglutination [Presence] in Blood

167

0.90

0.10

3.0

3.2

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

1.11

0.09

1.2

1.46

1.76

mmol/l

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

576

1.04

0.09

2.5

161.50

110.69

ug/min

0.22

357

(40768800) Prostate Pathology biopsy report

311

1.06

0.09

1.1

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

177

1734

1.02

0.09

1.6

1.5

62.19

60.71

ug/l

0.18

151

1459

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.81

0.08

10.2

6.4

6.20

5.09

kpa

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.08

0.08

1.0

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.83

0.07

1.0

1.3

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

1.05

0.07

1.6

1.1

—

(3022689) Creatine [Moles/volume] in Urine

100

0.90

0.06

1.4

1.6

10.30

8.44

mmol/l

—

100

(3000012) Reticulocyte production index

335

1.05

0.06

1.7

2.2

1.04

0.89

0.61

220

(3051387) C reactive protein [Mass/volume] in Capillary blood

628

0.97

0.06

3.6

3.4

28.35

25.05

mg/l

0.32

431

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.11

0.05

2.0

1.5

7.70

8.70

ug/l

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

221

0.95

0.04

1.8

2.2

1.38

1.91

u/field

0.45

129

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

150

1.07

0.04

2.8

2.5

47.75

53.07

umol/l

0.30

134

(4281824) Cell count and differential, peritoneal fluid

351

0.97

0.03

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

600

0.98

0.02

5.3

4.0

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

157

1558

1.01

0.02

1.1

1.49

1.54

g/l

2.18

157

1558

(3026470) Cobalt [Mass/volume] in Blood

133

1.05

0.01

2.4

2.2

3.98

3.26

ug/l

0.12

125

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

147

1477

1.00

0.00

1.1

0.68

0.62

ratio

0.36

161

(40765089) Chromosome analysis panel - Blood by G-banded

174

1.03

0.00

1.0

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

158

1.01

0.00

2.8

3.2

1.62

1.42

ug/l

0.12

149

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3042517) Benzodiazepines panel - Urine

1.00

0.00

1.3

2.2

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.01

-0.00

1.0

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

0.99

-0.00

1.4

1.6

—

0.89

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.4

—

6.76

—

(3004982) Buprenorphine [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.8

—

2.02

—

(3013637) Mi-2 Ab [Presence] in Serum

1.01

-0.00

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.01

-0.00

1.0

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

190

1.00

-0.00

1.3

1.8

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

-0.00

0.0

1.3

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.01

-0.00

1.0

1.1

—

(3038702) Sodium [Moles/volume] in Capillary blood

0.00

-0.00

0.0

4.0

—

138.20

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

0.93

-0.00

1.2

1.3

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

-0.00

0.0

1.2

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_URTICA_ALLERG and mortality.

Females

Parameter	HR [95% CI]	p-value
L12_URTICA_ALLERG	1.201 [1.06, 1.36]	0.004
Birth year	0.998 [0.99, 1.01]	0.694

During the follow-up period (1.1.1998 — 31.12.2019), 1258 out of 15742 females with L12_URTICA_ALLERG died.

Males

Parameter	HR [95% CI]	p-value
L12_URTICA_ALLERG	1.402 [1.22, 1.61]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.01

During the follow-up period (1.1.1998 — 31.12.2019), 791 out of 11004 males with L12_URTICA_ALLERG died.

Mortality risk

Mortality risk for people of age

years, who have L12_URTICA_ALLERG.

N-year risk	Females	Males
1	0.141%	0.233%
5	0.869%	1.554%
10	2.144%	4.065%
15	3.882%	7.337%
20	6.668%	12.586%

Relationships between endpoints

↥

Index endpoint: L12_URTICA_ALLERG – Allergic urticaria

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Allergic urticaria

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints